=== Generating (published_papers) === === Generating (teaching_experience) === === Generating (education) === === Generating (research_experience) === === Generating (misc) === === Generating (research_projects) === === Generating (books_etc) === === Generating (committee_memberships) === === Generating (awards) === === Generating (association_memberships) === === Generating (presentations) === ==== begin registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/published_papers.jsonl) ==== line:1, {"insert":{"user_id":"R000010784","type":"published_papers","id":"33896143"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34597687","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=382305","label":"url"}],"paper_title":{"en":"p.Asn77Lys homozygous CLN6 mutation in two unrelated Japanese patients with Kufs disease, an adult onset neuronal ceroid lipofuscinosis.","ja":"p.Asn77Lys homozygous CLN6 mutation in two unrelated Japanese patients with Kufs disease, an adult onset neuronal ceroid lipofuscinosis."},"authors":{"en":[{"name":"Onodera Misaki"},{"name":"Tsujimoto Saori"},{"name":"Doi Syusuke"},{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"},{"name":"Makifuchi Takao"},{"name":"Inazu Tetsuya"}],"ja":[{"name":"Onodera Misaki"},{"name":"Tsujimoto Saori"},{"name":"Doi Syusuke"},{"name":"山下 ありさ"},{"name":"山﨑 哲男"},{"name":"Makifuchi Takao"},{"name":"Inazu Tetsuya"}]},"description":{"en":"Gene analysis results of the first patient revealed a homozygous mutation c231C>G, p.Asn77Lys in exon 3 and a homozygous c.297+48 A>T mutation in intron 3 in the CLN6 gene. The Asn amino acid is perfectly conserved among species. In silico analysis showed that the mutation is predicted to be probably damaging. Moreover, the second patient with Kufs disease also had the same homozygous mutations. These data suggest that the missense mutation must be pathogenic. Furthermore, the patients had lived in the same district; therefore, they both potentially inherited the founder effect mutations.","ja":"Gene analysis results of the first patient revealed a homozygous mutation c231C>G, p.Asn77Lys in exon 3 and a homozygous c.297+48 A>T mutation in intron 3 in the CLN6 gene. The Asn amino acid is perfectly conserved among species. In silico analysis showed that the mutation is predicted to be probably damaging. Moreover, the second patient with Kufs disease also had the same homozygous mutations. These data suggest that the missense mutation must be pathogenic. Furthermore, the patients had lived in the same district; therefore, they both potentially inherited the founder effect mutations."},"publication_date":"2021-09-28","publication_name":{"en":"Clinica Chimica Acta","ja":"Clinica Chimica Acta"},"volume":"Vol.523","number":"No.21","starting_page":"191","ending_page":"195","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.cca.2021.09.021"],"issn":["1873-3492"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"R000010784","type":"published_papers","id":"33335783"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116174","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34380921","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379112","label":"url"}],"paper_title":{"en":"CLN6's luminal tail-mediated functional interference between CLN6 mutants as a novel pathomechanism for the neuronal ceroid lipofuscinoses.","ja":"CLN6's luminal tail-mediated functional interference between CLN6 mutants as a novel pathomechanism for the neuronal ceroid lipofuscinoses."},"authors":{"en":[{"name":"Shiro Yuki"},{"name":"Yamashita Arisa"},{"name":"Watanabe Kana"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山下 ありさ"},{"name":"渡邊 佳奈"},{"name":"山﨑 哲男"}]},"description":{"en":"CLN6 (Ceroid Lipofuscinosis, Neuronal, 6) is a 311-amino acid protein spanning the endoplasmic reticulum membrane. Mutations in CLN6 are linked to CLN6 disease, a hereditary neurodegenerative disorder categorized into the neuronal ceroid lipofuscinoses. CLN6 disease is an autosomal recessive disorder and individuals affected with this disease have two identical (homozygous) or two distinct (compound heterozygous) CLN6 mutant alleles. Little has been known about CLN6's physiological roles and the disease mechanism. We recently found that CLN6 prevents protein aggregate formation, pointing to impaired CLN6's anti-aggregate activity as a cause for the disease. To comprehensively understand the pathomechanism, overall anti-aggregate activity derived from two different CLN6 mutants needs to be investigated, considering patients compound heterozygous for CLN6 alleles. We focused on mutant combinations involving the S132CfsX18 (132fsX) prematurely terminated protein, produced from the most frequent mutation in CLN6. The 132fsX mutant nullified anti-aggregate activity of the P299L CLN6 missense mutant but not of wild-type CLN6. Wild-type CLN6's resistance to the 132fsX mutant was abolished by replacement of amino acids 297-301, including Pro297 and Pro299, with five alanine residues. Given that removal of CLN6's C-terminal fifteen amino acids 297-311 (luminal tail) did not affect the resistance, we suggested that CLN6's luminal tail, when unleashed from Pro297/299-mediated conformational constraints, is improperly positioned by the 132fsX mutant, thereby blocking the induction of anti- aggregate activity. We here reveal a novel mechanism for dissipating CLN6 mutants' residual functions, providing an explanation for the compound heterozygosity-driven pathogenesis.","ja":"CLN6 (Ceroid Lipofuscinosis, Neuronal, 6) is a 311-amino acid protein spanning the endoplasmic reticulum membrane. Mutations in CLN6 are linked to CLN6 disease, a hereditary neurodegenerative disorder categorized into the neuronal ceroid lipofuscinoses. CLN6 disease is an autosomal recessive disorder and individuals affected with this disease have two identical (homozygous) or two distinct (compound heterozygous) CLN6 mutant alleles. Little has been known about CLN6's physiological roles and the disease mechanism. We recently found that CLN6 prevents protein aggregate formation, pointing to impaired CLN6's anti-aggregate activity as a cause for the disease. To comprehensively understand the pathomechanism, overall anti-aggregate activity derived from two different CLN6 mutants needs to be investigated, considering patients compound heterozygous for CLN6 alleles. We focused on mutant combinations involving the S132CfsX18 (132fsX) prematurely terminated protein, produced from the most frequent mutation in CLN6. The 132fsX mutant nullified anti-aggregate activity of the P299L CLN6 missense mutant but not of wild-type CLN6. Wild-type CLN6's resistance to the 132fsX mutant was abolished by replacement of amino acids 297-301, including Pro297 and Pro299, with five alanine residues. Given that removal of CLN6's C-terminal fifteen amino acids 297-311 (luminal tail) did not affect the resistance, we suggested that CLN6's luminal tail, when unleashed from Pro297/299-mediated conformational constraints, is improperly positioned by the 132fsX mutant, thereby blocking the induction of anti- aggregate activity. We here reveal a novel mechanism for dissipating CLN6 mutants' residual functions, providing an explanation for the compound heterozygosity-driven pathogenesis."},"publication_date":"2021-08-12","publication_name":{"en":"Biomedical Research","ja":"Biomedical Research"},"volume":"Vol.42","number":"No.4","starting_page":"129","ending_page":"138","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2220/biomedres.42.129"],"issn":["1880-313X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377056"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/114612","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32171521","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=365262","label":"url"}],"paper_title":{"en":"Implications of graded reductions in CLN6's anti-aggregate activity for the development of the neuronal ceroid lipofuscinoses.","ja":"Implications of graded reductions in CLN6's anti-aggregate activity for the development of the neuronal ceroid lipofuscinoses."},"authors":{"en":[{"name":"Yamashita Arisa"},{"name":"Shiro Yuki"},{"name":"Hiraki Yuri"},{"name":"Yujiri Takatoshi"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"城 裕己"},{"name":"平木 友理"},{"name":"湯尻 貴俊"},{"name":"山﨑 哲男"}]},"description":{"en":"CLN6, spanning the endoplasmic reticulum membrane, is a protein of unknown function. Mutations in the CLN6 gene are linked to an autosomal recessively inherited disorder termed CLN6 disease, classified as a form of the neuronal ceroid lipofuscinoses (NCL). The pathogenesis of CLN6 disease remains poorly understood due to a lack of information about physiological roles CLN6 plays. We previously demonstrated that CLN6 has the ability to prevent protein aggregate formation, and thus hypothesized that the abrogation of CLN6's anti-aggregate activity underlies the development of CLN6 disease. To test this hypothesis, we narrowed down the region vital for CLN6's anti-aggregate activity, and subsequently investigated if pathogenic mutations within the region attenuate CLN6's anti-aggregate activity toward four aggregation-prone αB-crystallin (αBC) mutants. None of the four αBC mutants was prevented from aggregating by the Arg106ProfsX truncated CLN6 mutant, the human counterpart of the nclf mutant identified in a naturally occurring mouse model of late infantile-onset CLN6 disease. In contrast, the Arg149Cys and the Arg149His CLN6 mutants, both associated with adult-onset CLN6 disease, blocked aggregation of two out of and all of the four αBC mutants, respectively, indicating that CLN6's anti-aggregate activity is differentially modulated according to the substitution pattern at the same amino acid position. Collectively, we here propose that the graded reduction in CLN6's anti-aggregate activity governs the clinical course of late infantile- and adult-onset NCL.","ja":"CLN6, spanning the endoplasmic reticulum membrane, is a protein of unknown function. Mutations in the CLN6 gene are linked to an autosomal recessively inherited disorder termed CLN6 disease, classified as a form of the neuronal ceroid lipofuscinoses (NCL). The pathogenesis of CLN6 disease remains poorly understood due to a lack of information about physiological roles CLN6 plays. We previously demonstrated that CLN6 has the ability to prevent protein aggregate formation, and thus hypothesized that the abrogation of CLN6's anti-aggregate activity underlies the development of CLN6 disease. To test this hypothesis, we narrowed down the region vital for CLN6's anti-aggregate activity, and subsequently investigated if pathogenic mutations within the region attenuate CLN6's anti-aggregate activity toward four aggregation-prone αB-crystallin (αBC) mutants. None of the four αBC mutants was prevented from aggregating by the Arg106ProfsX truncated CLN6 mutant, the human counterpart of the nclf mutant identified in a naturally occurring mouse model of late infantile-onset CLN6 disease. In contrast, the Arg149Cys and the Arg149His CLN6 mutants, both associated with adult-onset CLN6 disease, blocked aggregation of two out of and all of the four αBC mutants, respectively, indicating that CLN6's anti-aggregate activity is differentially modulated according to the substitution pattern at the same amino acid position. Collectively, we here propose that the graded reduction in CLN6's anti-aggregate activity governs the clinical course of late infantile- and adult-onset NCL."},"publication_date":"2020-03-11","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.525","number":"No.4","starting_page":"883","ending_page":"888","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2020.03.019"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377057"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/111526","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28476624","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=324668","label":"url"}],"paper_title":{"en":"Identification of CLN6 as a molecular entity of endoplasmic reticulum-driven anti-aggregate activity","ja":"Identification of CLN6 as a molecular entity of endoplasmic reticulum-driven anti-aggregate activity"},"authors":{"en":[{"name":"Yamashita Arisa"},{"name":"Hiraki Yuri"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"平木 友理"},{"name":"山﨑 哲男"}]},"description":{"en":"B-crystallin (BC) is a small heat shock protein. Mutations in the BC gene are linked to -crystallinopathy, a hereditary myopathy histologically characterized by intracellular accumulation of protein aggregates. The disease-causing R120G BC mutant, harboring an arginine-to-glycine replacement at position 120, is an aggregate-prone protein. We previously showed that the R120G mutant's aggregation in HeLa cells was prevented by enforced expression of BC on the endoplasmic reticulum (ER). To elucidate the molecular nature of the preventive effect on the R120G mutant, we isolated proteins binding to ER-anchored BC (TMBC). The ER transmembrane CLN6 protein was identified as a TMBC's binder. CLN6 knockdown in HeLa cells attenuated TMBC's anti-aggregate activity against the R120G mutant. Conversely, CLN6 overexpression enhanced the activity, indicating that CLN6 operates as a downstream effector of TMBC. CLN6 physically interacted with the R120G mutant, and repressed its aggregation in HeLa cells even when TMBC was not co-expressed. Furthermore, CLN6's antagonizing effect on the R120G mutant was compromised upon treatment with a lysosomal inhibitor, suggesting CLN6 requires the intact autophagy-lysosome system to prevent the R120G mutant from aggregating. We hence conclude that CLN6 is not only a molecular entity of the anti-aggregate activity conferred by the ER manipulation using TMBC, but also serves as a potential target of therapeutic interventions.","ja":"B-crystallin (BC) is a small heat shock protein. Mutations in the BC gene are linked to -crystallinopathy, a hereditary myopathy histologically characterized by intracellular accumulation of protein aggregates. The disease-causing R120G BC mutant, harboring an arginine-to-glycine replacement at position 120, is an aggregate-prone protein. We previously showed that the R120G mutant's aggregation in HeLa cells was prevented by enforced expression of BC on the endoplasmic reticulum (ER). To elucidate the molecular nature of the preventive effect on the R120G mutant, we isolated proteins binding to ER-anchored BC (TMBC). The ER transmembrane CLN6 protein was identified as a TMBC's binder. CLN6 knockdown in HeLa cells attenuated TMBC's anti-aggregate activity against the R120G mutant. Conversely, CLN6 overexpression enhanced the activity, indicating that CLN6 operates as a downstream effector of TMBC. CLN6 physically interacted with the R120G mutant, and repressed its aggregation in HeLa cells even when TMBC was not co-expressed. Furthermore, CLN6's antagonizing effect on the R120G mutant was compromised upon treatment with a lysosomal inhibitor, suggesting CLN6 requires the intact autophagy-lysosome system to prevent the R120G mutant from aggregating. We hence conclude that CLN6 is not only a molecular entity of the anti-aggregate activity conferred by the ER manipulation using TMBC, but also serves as a potential target of therapeutic interventions."},"publication_date":"2017-05-01","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.487","number":"No.4","starting_page":"917","ending_page":"922","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2017.05.002"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377058"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25449278","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=288566","label":"url"}],"paper_title":{"en":"Prevention of aberrant protein aggregation by anchoring the molecular chaperone B-crystallin to the endoplasmic reticulum.","ja":"Prevention of aberrant protein aggregation by anchoring the molecular chaperone B-crystallin to the endoplasmic reticulum."},"authors":{"en":[{"name":"Yamamto Shin-ichiro"},{"name":"Yamashita Arisa"},{"name":"Arakaki Naokatu"},{"name":"Nemoto Hisao"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山本 伸一郎"},{"name":"山下 ありさ"},{"name":"新垣 尚捷"},{"name":"根本 尚夫"},{"name":"山﨑 哲男"}]},"description":{"en":"The chaperone B-crystallin (BC) is a member of the small heat shock protein family and its point or truncated mutants cause the muscular disorder -crystallinopathy. The illness is histologically characterized by accumulation of protein aggregates in muscle cells. Expression of the myopathy-causing R120G mutant of BC, harboring an arginine-to-glycine mutation at position 120, results in aggregate formation. We demonstrated that tethering BC to the endoplasmic reticulum (ER) membrane represses the protein aggregation mediated by the R120G mutant. ER-anchored BC decreased the amount of the R120G mutant through autophagic proteolysis. In contrast, knockdown of ATG5, an E3 ligase essential for autophagy, in ER-anchored BC-transfected cells restored the quantity of the R120G mutant. In this context, aggregate formation was still suppressed, indicating that ER-anchored BC profoundly constrains aggregation competency of the R120G mutant separately from downregulating the abundance of the mutant. We have proposed that protein aggregation is prevented by manipulation of the ER microenvironment with BC, and have shed light on a novel aspect of the ER as a therapeutic target.","ja":"The chaperone B-crystallin (BC) is a member of the small heat shock protein family and its point or truncated mutants cause the muscular disorder -crystallinopathy. The illness is histologically characterized by accumulation of protein aggregates in muscle cells. Expression of the myopathy-causing R120G mutant of BC, harboring an arginine-to-glycine mutation at position 120, results in aggregate formation. We demonstrated that tethering BC to the endoplasmic reticulum (ER) membrane represses the protein aggregation mediated by the R120G mutant. ER-anchored BC decreased the amount of the R120G mutant through autophagic proteolysis. In contrast, knockdown of ATG5, an E3 ligase essential for autophagy, in ER-anchored BC-transfected cells restored the quantity of the R120G mutant. In this context, aggregate formation was still suppressed, indicating that ER-anchored BC profoundly constrains aggregation competency of the R120G mutant separately from downregulating the abundance of the mutant. We have proposed that protein aggregation is prevented by manipulation of the ER microenvironment with BC, and have shed light on a novel aspect of the ER as a therapeutic target."},"publication_date":"2014-11-06","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.455","number":"No.3-4","starting_page":"241","ending_page":"245","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2014.10.151"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377059"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25009997","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=283806","label":"url"}],"paper_title":{"en":"Contribution of calumin to embryogenesis through participation in the endoplasmic reticulum-associated degradation activity.","ja":"Contribution of calumin to embryogenesis through participation in the endoplasmic reticulum-associated degradation activity."},"authors":{"en":[{"name":"Yamamto Shin-ichiro"},{"name":"Yamazaki Tetsuo"},{"name":"Komazaki Shinji"},{"name":"Yamashita Takeshi"},{"name":"Osaki Masako"},{"name":"Matsubayashi Masaya"},{"name":"Kidoya Hiroyasu"},{"name":"Takakura Nobuyuki"},{"name":"Yamazaki Daiju"},{"name":"Kakizawa Sho"}],"ja":[{"name":"山本 伸一郎"},{"name":"山﨑 哲男"},{"name":"Komazaki Shinji"},{"name":"Yamashita Takeshi"},{"name":"Osaki Masako"},{"name":"Matsubayashi Masaya"},{"name":"Kidoya Hiroyasu"},{"name":"Takakura Nobuyuki"},{"name":"Yamazaki Daiju"},{"name":"Kakizawa Sho"}]},"description":{"en":"Calumin is an endoplasmic reticulum (ER)-transmembrane protein, and little is known about its physiological roles. Here we showed that calumin homozygous mutant embryos die at embryonic days (E) 10.5-11.5. At mid-gestation, calumin was expressed predominantly in the yolk sac. Apoptosis was enhanced in calumin homozygous mutant yolk sacs at E9.5, pointing to a possible link to the embryonic lethality. Calumin co-immunoprecipitated with ERAD components such as p97, BIP, derlin-1, derlin-2 and VIMP, suggesting its involvement in ERAD. Indeed, calumin knockdown in HEK 293 cells resulted in ERAD being less efficient, as demonstrated by attenuation in both degradations of a misfolded 1-antitrypsin variant and the ER-to-cytosol dislocation of cholera toxin A1 subunit. In calumin homozygous mutant yolk sac endoderm cells, ER stress-associated alterations were observed, including lipid droplet accumulation, fragmentation of the ER and dissociation of ribosomes from the ER. In this context, the ER-overload response, assumed to be cytoprotective, was also triggered in the mutant endoderm cells, but seemed to fully counteract the excessive ER stress generated due to defective ERAD. Taken together, our findings suggested that calumin serves to maintain the yolk sac integrity through participation in the ERAD activity, contributing to embryonic development.","ja":"Calumin is an endoplasmic reticulum (ER)-transmembrane protein, and little is known about its physiological roles. Here we showed that calumin homozygous mutant embryos die at embryonic days (E) 10.5-11.5. At mid-gestation, calumin was expressed predominantly in the yolk sac. Apoptosis was enhanced in calumin homozygous mutant yolk sacs at E9.5, pointing to a possible link to the embryonic lethality. Calumin co-immunoprecipitated with ERAD components such as p97, BIP, derlin-1, derlin-2 and VIMP, suggesting its involvement in ERAD. Indeed, calumin knockdown in HEK 293 cells resulted in ERAD being less efficient, as demonstrated by attenuation in both degradations of a misfolded 1-antitrypsin variant and the ER-to-cytosol dislocation of cholera toxin A1 subunit. In calumin homozygous mutant yolk sac endoderm cells, ER stress-associated alterations were observed, including lipid droplet accumulation, fragmentation of the ER and dissociation of ribosomes from the ER. In this context, the ER-overload response, assumed to be cytoprotective, was also triggered in the mutant endoderm cells, but seemed to fully counteract the excessive ER stress generated due to defective ERAD. Taken together, our findings suggested that calumin serves to maintain the yolk sac integrity through participation in the ERAD activity, contributing to embryonic development."},"publication_date":"2014-07-08","publication_name":{"en":"Developmental Biology","ja":"Developmental Biology"},"volume":"Vol.393","number":"No.1","starting_page":"33","ending_page":"43","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.ydbio.2014.06.024"],"issn":["1095-564X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377060"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23782750","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84879139579&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=263468","label":"url"}],"paper_title":{"en":"Involvement of reactive oxygen species in osteoblastic differentiation of MC3T3-E1 cells accompanied by mitochondrial morphological dynamics.","ja":"Involvement of reactive oxygen species in osteoblastic differentiation of MC3T3-E1 cells accompanied by mitochondrial morphological dynamics."},"authors":{"en":[{"name":"Arakaki Naokatu"},{"name":"Yamashita Arisa"},{"name":"Niimi Shingo"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"新垣 尚捷"},{"name":"山下 ありさ"},{"name":"Niimi Shingo"},{"name":"山﨑 哲男"}]},"description":{"en":"Bone remodeling is regulated by local factors that regulate bone-forming osteoblasts and boneresorbing osteoclasts, in addition to hormonal activity. Recent studies have shown that reactive oxygen species (ROS) act as an intracellular signal mediator for osteoclast differentiation. However the role of ROS on osteoblast differentiation is poorly understood. Here, we investigated the impact of ROS on osteoblastic differentiation of MC3T3-E1 cells. Osteogenic induction resulted in notable enhancement of mineralization and expression of osteogenic marker gene alkaline phosphatase, which were accompanied by an increase in ROS production. Additionally, we found that mitochondrial morphology dynamically changed from tubular reticulum to fragmented structures during the differentiation, suggesting that mitochondrial morphological transition is a novel osteoblast differentiation index. The antioxidant N-acetyl cysteine prevented not only ROS production but also mineralization and mitochondrial fragmentation. It is therefore suggested that the ROSdependent signaling pathways play a role in osteoblast differentiation accompanied by mitochondrial morphological transition.","ja":"Bone remodeling is regulated by local factors that regulate bone-forming osteoblasts and boneresorbing osteoclasts, in addition to hormonal activity. Recent studies have shown that reactive oxygen species (ROS) act as an intracellular signal mediator for osteoclast differentiation. However the role of ROS on osteoblast differentiation is poorly understood. Here, we investigated the impact of ROS on osteoblastic differentiation of MC3T3-E1 cells. Osteogenic induction resulted in notable enhancement of mineralization and expression of osteogenic marker gene alkaline phosphatase, which were accompanied by an increase in ROS production. Additionally, we found that mitochondrial morphology dynamically changed from tubular reticulum to fragmented structures during the differentiation, suggesting that mitochondrial morphological transition is a novel osteoblast differentiation index. The antioxidant N-acetyl cysteine prevented not only ROS production but also mineralization and mitochondrial fragmentation. It is therefore suggested that the ROSdependent signaling pathways play a role in osteoblast differentiation accompanied by mitochondrial morphological transition."},"publication_date":"2013-06-19","publication_name":{"en":"Biomedical Research","ja":"Biomedical Research"},"volume":"Vol.34","number":"No.3","starting_page":"161","ending_page":"166","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2220/biomedres.34.161"],"issn":["1880-313X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377061"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23542032","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84876498476&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=261612","label":"url"}],"paper_title":{"en":"Protective role of the endoplasmic reticulum protein mitsugumin23 against ultraviolet C-induced cell death.","ja":"Protective role of the endoplasmic reticulum protein mitsugumin23 against ultraviolet C-induced cell death."},"authors":{"en":[{"name":"Yamashita Arisa"},{"name":"Taniwaki Tatsuya"},{"name":"Kaikoi Yuka"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"谷脇 竜弥"},{"name":"海古井 由佳"},{"name":"山﨑 哲男"}]},"description":{"en":"The endoplasmic reticulum (ER) operates in adaptive responses to various stresses, dictating cell fate. Here we show that knockdown of the ER protein mitsugumin23 (MG23) enhances cell death induced by ultraviolet C (UVC), which causes DNA damage. The small heat shock protein B-crystallin (BC) is identified as a MG23 binding molecule and its knockdown facilitates death of UVC-exposed cells. Conversely, BC lowered UVC sensitivity when expressed as an ER-anchored form. Taken together, the results suggest that MG23 plays a protective role against UVC by accumulating BC in the close vicinity of the ER.","ja":"The endoplasmic reticulum (ER) operates in adaptive responses to various stresses, dictating cell fate. Here we show that knockdown of the ER protein mitsugumin23 (MG23) enhances cell death induced by ultraviolet C (UVC), which causes DNA damage. The small heat shock protein B-crystallin (BC) is identified as a MG23 binding molecule and its knockdown facilitates death of UVC-exposed cells. Conversely, BC lowered UVC sensitivity when expressed as an ER-anchored form. Taken together, the results suggest that MG23 plays a protective role against UVC by accumulating BC in the close vicinity of the ER."},"publication_date":"2013-03-28","publication_name":{"en":"FEBS Letters","ja":"FEBS Letters"},"volume":"Vol.587","number":"No.9","starting_page":"1299","ending_page":"1303","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.febslet.2013.03.024"],"issn":["1873-3468"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:9, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377062"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22187460","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=243871","label":"url"}],"paper_title":{"en":"Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt.","ja":"Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt."},"authors":{"en":[{"name":"Troutman Ty Dale"},{"name":"Hu Wei"},{"name":"Fulenchek Stephanie"},{"name":"Yamazaki Tetsuo"},{"name":"Kurosaki Tomohiro"},{"name":"Bazan J Fernando"},{"name":"Pasare Chandrashekhar"}],"ja":[{"name":"Troutman Ty Dale"},{"name":"Hu Wei"},{"name":"Fulenchek Stephanie"},{"name":"山﨑 哲男"},{"name":"Kurosaki Tomohiro"},{"name":"Bazan J Fernando"},{"name":"Pasare Chandrashekhar"}]},"description":{"en":"Toll like receptors (TLRs) use Toll-IL-1 receptor (TIR) domain-containing adapters, such as myeloid differentiation primary response gene 88 (MyD88) and TIR domain-containing adapter inducing IFN- (TRIF), to induce activation of transcription factors, including NF-B, MAP kinases, and IFN regulatory factors. TLR signaling also leads to activation of PI3K, but the molecular mechanism is not understood. Here we have discovered a unique role for B-cell adapter for PI3K (BCAP) in the TLR-signaling pathway. We find that BCAP has a functional N-terminal TIR homology domain and links TLR signaling to activation of PI3K. In addition, BCAP negatively regulates proinflammatory cytokine secretion upon TLR stimulation. In vivo, the absence of BCAP leads to exaggerated recruitment of inflammatory myeloid cells following infections and enhanced susceptibility to dextran sulfate sodium-induced colitis. Our results demonstrate that BCAP is a unique TIR domain-containing TLR signaling adapter crucial for linking TLRs to PI3K activation and regulating the inflammatory response.","ja":"Toll like receptors (TLRs) use Toll-IL-1 receptor (TIR) domain-containing adapters, such as myeloid differentiation primary response gene 88 (MyD88) and TIR domain-containing adapter inducing IFN- (TRIF), to induce activation of transcription factors, including NF-B, MAP kinases, and IFN regulatory factors. TLR signaling also leads to activation of PI3K, but the molecular mechanism is not understood. Here we have discovered a unique role for B-cell adapter for PI3K (BCAP) in the TLR-signaling pathway. We find that BCAP has a functional N-terminal TIR homology domain and links TLR signaling to activation of PI3K. In addition, BCAP negatively regulates proinflammatory cytokine secretion upon TLR stimulation. In vivo, the absence of BCAP leads to exaggerated recruitment of inflammatory myeloid cells following infections and enhanced susceptibility to dextran sulfate sodium-induced colitis. Our results demonstrate that BCAP is a unique TIR domain-containing TLR signaling adapter crucial for linking TLRs to PI3K activation and regulating the inflammatory response."},"publication_date":"2011-12-20","publication_name":{"en":"Proceedings of the National Academy of Sciences of the United States of America","ja":"Proceedings of the National Academy of Sciences of the United States of America"},"volume":"Vol.109","number":"No.1","starting_page":"273","ending_page":"278","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1073/pnas.1118579109"],"issn":["1091-6490"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:10, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377063"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21685326","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233810","label":"url"}],"paper_title":{"en":"A Requirement for the p85 PI3K Adapter Protein BCAP in the Protection of Macrophages from Apoptosis Induced by Endoplasmic Reticulum Stress.","ja":"A Requirement for the p85 PI3K Adapter Protein BCAP in the Protection of Macrophages from Apoptosis Induced by Endoplasmic Reticulum Stress."},"authors":{"en":[{"name":"Song Sungwon"},{"name":"Chew Claude"},{"name":"Dale M. Benjamin"},{"name":"Traum Daniel"},{"name":"Peacock James"},{"name":"Yamazaki Tetsuo"},{"name":"Clynes Raphael"},{"name":"Kurosaki Tomohiro"},{"name":"Greenberg Steven"}],"ja":[{"name":"Song Sungwon"},{"name":"Chew Claude"},{"name":"Dale M. Benjamin"},{"name":"Traum Daniel"},{"name":"Peacock James"},{"name":"山﨑 哲男"},{"name":"Clynes Raphael"},{"name":"Kurosaki Tomohiro"},{"name":"Greenberg Steven"}]},"description":{"en":"Macrophages are innate immune cells that play key roles in regulation of the immune response and in tissue injury and repair. In response to specific innate immune stimuli, macrophages may exhibit signs of endoplasmic reticulum (ER) stress and progress to apoptosis. Factors that regulate macrophage survival under these conditions are poorly understood. In this study, we identified B cell adapter protein (BCAP), a p85 PI3K-binding adapter protein, in promoting survival in response to the combined challenge of LPS and ER stress. BCAP was unique among nine PI3K adapter proteins in being induced >10-fold in response to LPS. LPS-stimulated macrophages incubated with thapsigargin, a sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor that induces ER stress, underwent caspase-3 activation and apoptosis. Macrophages from BCAP(-/-) mice exhibited increased apoptosis in response to these stimuli. BCAP-deficient macrophages demonstrated decreased activation of Akt, but not ERK, and, unlike BCAP-deficient B cells, expressed normal amounts of the NF-B subunits, c-Rel and RelA. Retroviral transduction of BCAP-deficient macrophages with wild-type BCAP, but not a Y4F BCAP mutant defective in binding the SH2 domain of p85 PI3K, reversed the proapoptotic phenotype observed in BCAP-deficient macrophages. We conclude that BCAP is a nonredundant PI3K adapter protein in macrophages that is required for maximal cell survival in response to ER stress. We suggest that as macrophages engage their pathogenic targets, innate immune receptors trigger increased expression of BCAP, which endows them with the capacity to withstand further challenges from ongoing cellular insults, such as ER stress.","ja":"Macrophages are innate immune cells that play key roles in regulation of the immune response and in tissue injury and repair. In response to specific innate immune stimuli, macrophages may exhibit signs of endoplasmic reticulum (ER) stress and progress to apoptosis. Factors that regulate macrophage survival under these conditions are poorly understood. In this study, we identified B cell adapter protein (BCAP), a p85 PI3K-binding adapter protein, in promoting survival in response to the combined challenge of LPS and ER stress. BCAP was unique among nine PI3K adapter proteins in being induced >10-fold in response to LPS. LPS-stimulated macrophages incubated with thapsigargin, a sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor that induces ER stress, underwent caspase-3 activation and apoptosis. Macrophages from BCAP(-/-) mice exhibited increased apoptosis in response to these stimuli. BCAP-deficient macrophages demonstrated decreased activation of Akt, but not ERK, and, unlike BCAP-deficient B cells, expressed normal amounts of the NF-B subunits, c-Rel and RelA. Retroviral transduction of BCAP-deficient macrophages with wild-type BCAP, but not a Y4F BCAP mutant defective in binding the SH2 domain of p85 PI3K, reversed the proapoptotic phenotype observed in BCAP-deficient macrophages. We conclude that BCAP is a nonredundant PI3K adapter protein in macrophages that is required for maximal cell survival in response to ER stress. We suggest that as macrophages engage their pathogenic targets, innate immune receptors trigger increased expression of BCAP, which endows them with the capacity to withstand further challenges from ongoing cellular insults, such as ER stress."},"publication_date":"2011-06-17","publication_name":{"en":"The Journal of Immunology","ja":"The Journal of Immunology"},"volume":"Vol.187","number":"No.2","starting_page":"619","ending_page":"625","languages":["eng"],"referee":true,"identifiers":{"doi":["10.4049/jimmunol.0903425"],"issn":["1550-6606"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:11, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377064"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/10027651740/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001205257545984/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=226673","label":"url"}],"paper_title":{"en":"Role of cell surface H+-ATP synthase on adipocyte differentiation.","ja":"Role of cell surface H+-ATP synthase on adipocyte differentiation."},"authors":{"en":[{"name":"Toshiyuki Kita"},{"name":"Hana Nishida"},{"name":"Shingo Niimi"},{"name":"Shibata Hirofumi"},{"name":"Yamazaki Tetsuo"},{"name":"Arakaki Naokatu"}],"ja":[{"name":"Toshiyuki Kita"},{"name":"Hana Nishida"},{"name":"Shingo Niimi"},{"name":"柴田 洋文"},{"name":"山﨑 哲男"},{"name":"新垣 尚捷"}]},"publication_date":"2010-05","publication_name":{"en":"Inflammation and Regeneration","ja":"Inflammation and Regeneration"},"volume":"Vol.30","number":"No.5","starting_page":"425","ending_page":"427","languages":["eng"],"referee":true,"invited":true,"identifiers":{"doi":["10.2492/inflammregen.30.425"],"issn":["1880-9693"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:12, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377065"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20060811","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=210452","label":"url"}],"paper_title":{"en":"Facilitation of DNA damage-induced apoptosis by endoplasmic reticulum protein mitsugumin23.","ja":"Facilitation of DNA damage-induced apoptosis by endoplasmic reticulum protein mitsugumin23."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Sasaki Nozomi"},{"name":"Nishi Miyuki"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"山﨑 哲男"},{"name":"Sasaki Nozomi"},{"name":"Nishi Miyuki"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"The endoplasmic reticulum (ER) emanates context-dependent signals, thereby mediating cellular response to a variety of stresses. However, the underlying molecular mechanisms have been enigmatic. To better understand the signaling capacity of the ER, we focused on roles played by mitsugumin23 (MG23), a protein residing predominantly in this organelle. Overexpression of MG23 in human embryonic kidney 293T cells specifically enhanced apoptosis triggered by etoposide, a DNA-damaging anti-cancer drug. Conversely, genetic deletion of MG23 reduced susceptibility of thymocytes to DNA damage-induced apoptosis, which was demonstrated by whole-body irradiation experiments. In this setting, induction of the tumor-suppressor gene p53 was attenuated in MG23-knockout thymocytes as compared with their wild-type counterparts, consistent with the elevated radioresistance. It is therefore suggested that MG23 is an essential component of ER-generated lethal signals provoked upon DNA damage, specifying cell fate under pathophysiological conditions.","ja":"The endoplasmic reticulum (ER) emanates context-dependent signals, thereby mediating cellular response to a variety of stresses. However, the underlying molecular mechanisms have been enigmatic. To better understand the signaling capacity of the ER, we focused on roles played by mitsugumin23 (MG23), a protein residing predominantly in this organelle. Overexpression of MG23 in human embryonic kidney 293T cells specifically enhanced apoptosis triggered by etoposide, a DNA-damaging anti-cancer drug. Conversely, genetic deletion of MG23 reduced susceptibility of thymocytes to DNA damage-induced apoptosis, which was demonstrated by whole-body irradiation experiments. In this setting, induction of the tumor-suppressor gene p53 was attenuated in MG23-knockout thymocytes as compared with their wild-type counterparts, consistent with the elevated radioresistance. It is therefore suggested that MG23 is an essential component of ER-generated lethal signals provoked upon DNA damage, specifying cell fate under pathophysiological conditions."},"publication_date":"2010-01-12","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.392","number":"No.2","starting_page":"196","ending_page":"200","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2010.01.013"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:13, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377066"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19515693","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215079","label":"url"}],"paper_title":{"en":"Essential role of the TRIC-B channel in Ca2+ handling of alveolar epithelial cells and in perinatal lung maturation.","ja":"Essential role of the TRIC-B channel in Ca2+ handling of alveolar epithelial cells and in perinatal lung maturation."},"authors":{"en":[{"name":"Yamazaki Daiju"},{"name":"Komazaki Shinji"},{"name":"Nakanishi Hiroki"},{"name":"Mishima Aya"},{"name":"Nishi Miyuki"},{"name":"Yazawa Masayuki"},{"name":"Yamazaki Tetsuo"},{"name":"Taguchi Ryo"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Yamazaki Daiju"},{"name":"Komazaki Shinji"},{"name":"Nakanishi Hiroki"},{"name":"Mishima Aya"},{"name":"Nishi Miyuki"},{"name":"Yazawa Masayuki"},{"name":"山﨑 哲男"},{"name":"Taguchi Ryo"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"TRIC channels function as monovalent cation-specific channels that mediate counter ion movements coupled with ryanodine receptor-mediated Ca(2+) release from intracellular stores in muscle cells. Mammalian tissues differentially contain two TRIC channel subtypes: TRIC-A is abundantly expressed in excitable cells, whereas TRIC-B is ubiquitously expressed throughout tissues. Here, we report the physiological role of TRIC-B channels in mouse perinatal development. TRIC-B-knockout neonates were cyanotic owing to respiratory failure and died shortly after birth. In the mutant neonates, the deflated lungs exhibited severe histological defects, and alveolar type II epithelial cells displayed ultrastructural abnormalities. The metabolic conversion of glycogen into phospholipids was severely interrupted in the mutant type II cells, and surfactant phospholipids secreted into the alveolar space were insufficient in the mutant neonates. Moreover, the mutant type II cells were compromised for Ca(2+) release mediated by inositol-trisphosphate receptors, despite Ca(2+) overloading in intracellular stores. Our results indicate that TRIC-B channels take an active part in Ca(2+) signalling to establish specialised functions in type II cells and are thus essential for perinatal lung maturation.","ja":"TRIC channels function as monovalent cation-specific channels that mediate counter ion movements coupled with ryanodine receptor-mediated Ca(2+) release from intracellular stores in muscle cells. Mammalian tissues differentially contain two TRIC channel subtypes: TRIC-A is abundantly expressed in excitable cells, whereas TRIC-B is ubiquitously expressed throughout tissues. Here, we report the physiological role of TRIC-B channels in mouse perinatal development. TRIC-B-knockout neonates were cyanotic owing to respiratory failure and died shortly after birth. In the mutant neonates, the deflated lungs exhibited severe histological defects, and alveolar type II epithelial cells displayed ultrastructural abnormalities. The metabolic conversion of glycogen into phospholipids was severely interrupted in the mutant type II cells, and surfactant phospholipids secreted into the alveolar space were insufficient in the mutant neonates. Moreover, the mutant type II cells were compromised for Ca(2+) release mediated by inositol-trisphosphate receptors, despite Ca(2+) overloading in intracellular stores. Our results indicate that TRIC-B channels take an active part in Ca(2+) signalling to establish specialised functions in type II cells and are thus essential for perinatal lung maturation."},"publication_date":"2009-06-10","publication_name":{"en":"Development","ja":"Development"},"volume":"Vol.136","number":"No.14","starting_page":"2355","ending_page":"2361","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1242/dev.036798"],"issn":["0950-1991"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:14, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377067"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19202355","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-66149106316&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215078","label":"url"}],"paper_title":{"en":"Mitsugumin 53-mediated maintenance of K+ currents in cardiac myocytes.","ja":"Mitsugumin 53-mediated maintenance of K+ currents in cardiac myocytes."},"authors":{"en":[{"name":"Masumiya Haruko"},{"name":"Asaumi Yasuhide"},{"name":"Nishi Miyuki"},{"name":"Minamisawa Susumu"},{"name":"Adachi-Akahane Satomi"},{"name":"Yoshida Morikatsu"},{"name":"Kangawa Kenji"},{"name":"Ito Kenta"},{"name":"Kagaya Yutaka"},{"name":"Yanagisawa Teruyuki"},{"name":"Yamazaki Tetsuo"},{"name":"Ma Jianjie"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Masumiya Haruko"},{"name":"Asaumi Yasuhide"},{"name":"Nishi Miyuki"},{"name":"Minamisawa Susumu"},{"name":"Adachi-Akahane Satomi"},{"name":"Yoshida Morikatsu"},{"name":"Kangawa Kenji"},{"name":"Ito Kenta"},{"name":"Kagaya Yutaka"},{"name":"Yanagisawa Teruyuki"},{"name":"山﨑 哲男"},{"name":"Ma Jianjie"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"Mitsugumin 53 (MG53) is a muscle-specific RBCC/TRIM family member predominantly localized on small vesicles underneath the plasma membrane. Upon cell-surface lesion MG53 recruits the vesicles to the repair site in an oxidation-dependent manner and MG53-knockout mice develop progressive myopathy associated with defective membrane repair. In this report, we focus on MG53-knockout cardiomyocytes showing abnormal action potential profile and a reduced K+ current density. In cDNA expression experiments using cultured cells, KV2.1-mediated currents were remarkably increased by MG53 without affecting the total and cell-surface levels of channel expression. In imaging analysis MG53 seemed to facilitate the mobility of KV2.1-containing endocytic vesicles with acidic pH. However, similar effects on the current density and vesicular mobility were not observed in the putative dominant-negative form of MG53. Our data suggest that MG53 is involved in a constitutive cycle of certain cell-surface proteins between the plasma membrane and endosome-like vesicles in striated muscle, and also imply that the vesicular dynamics are essential for the quality control of KV2.1 in cardiomyocytes.","ja":"Mitsugumin 53 (MG53) is a muscle-specific RBCC/TRIM family member predominantly localized on small vesicles underneath the plasma membrane. Upon cell-surface lesion MG53 recruits the vesicles to the repair site in an oxidation-dependent manner and MG53-knockout mice develop progressive myopathy associated with defective membrane repair. In this report, we focus on MG53-knockout cardiomyocytes showing abnormal action potential profile and a reduced K+ current density. In cDNA expression experiments using cultured cells, KV2.1-mediated currents were remarkably increased by MG53 without affecting the total and cell-surface levels of channel expression. In imaging analysis MG53 seemed to facilitate the mobility of KV2.1-containing endocytic vesicles with acidic pH. However, similar effects on the current density and vesicular mobility were not observed in the putative dominant-negative form of MG53. Our data suggest that MG53 is involved in a constitutive cycle of certain cell-surface proteins between the plasma membrane and endosome-like vesicles in striated muscle, and also imply that the vesicular dynamics are essential for the quality control of KV2.1 in cardiomyocytes."},"publication_date":"2009-01-08","publication_name":{"en":"Channels","ja":"Channels"},"volume":"Vol.3","number":"No.1","starting_page":"6","ending_page":"11","languages":["eng"],"referee":true,"identifiers":{"doi":["10.4161/chan.3.1.7571"],"issn":["1933-6969"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:15, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377068"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18337558","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215076","label":"url"}],"paper_title":{"en":"Enhanced NK-cell development and function in BCAP-deficient mice.","ja":"Enhanced NK-cell development and function in BCAP-deficient mice."},"authors":{"en":[{"name":"MacFarlane W. Alexander"},{"name":"Yamazaki Tetsuo"},{"name":"Fang Min"},{"name":"Sigal J. Luis"},{"name":"Kurosaki Tomohiro"},{"name":"Campbell S. Kerry"}],"ja":[{"name":"MacFarlane W. Alexander"},{"name":"山﨑 哲男"},{"name":"Fang Min"},{"name":"Sigal J. Luis"},{"name":"Kurosaki Tomohiro"},{"name":"Campbell S. Kerry"}]},"description":{"en":"In B lymphocytes, the B-cell adaptor for phosphatidylinositol 3-kinase (BCAP) facilitates signaling from the antigen receptor. Mice lacking BCAP have a predominantly immature pool of B cells with impaired immune function and increased susceptibility to apoptosis. Unexpectedly, we have found that natural killer (NK) cells from BCAP-deficient mice are more mature, more long-lived, more resistant to apoptosis, and exhibit enhanced functional activity compared with NK cells from wild-type mice. Surprisingly, these effects are evident despite a severe impairment of the immunoreceptor tyrosine-based activation motif-mediated Akt signaling pathway. The seemingly paradoxical phenotype reveals inherent differences in the signals controlling the final maturation of B cells and NK cells, which depend on positive and negative signals, respectively. Both enhanced interferon-gamma responses and augmented maturation of NK cells in BCAP-deficient mice are independent of available MHC class I ligands. Our data support a model in which blunting of BCAP-mediated activation signaling in developing NK cells promotes functionality, terminal maturation, and long-term survival.","ja":"In B lymphocytes, the B-cell adaptor for phosphatidylinositol 3-kinase (BCAP) facilitates signaling from the antigen receptor. Mice lacking BCAP have a predominantly immature pool of B cells with impaired immune function and increased susceptibility to apoptosis. Unexpectedly, we have found that natural killer (NK) cells from BCAP-deficient mice are more mature, more long-lived, more resistant to apoptosis, and exhibit enhanced functional activity compared with NK cells from wild-type mice. Surprisingly, these effects are evident despite a severe impairment of the immunoreceptor tyrosine-based activation motif-mediated Akt signaling pathway. The seemingly paradoxical phenotype reveals inherent differences in the signals controlling the final maturation of B cells and NK cells, which depend on positive and negative signals, respectively. Both enhanced interferon-gamma responses and augmented maturation of NK cells in BCAP-deficient mice are independent of available MHC class I ligands. Our data support a model in which blunting of BCAP-mediated activation signaling in developing NK cells promotes functionality, terminal maturation, and long-term survival."},"publication_date":"2008-03-12","publication_name":{"en":"Blood","ja":"Blood"},"volume":"Vol.112","number":"No.1","starting_page":"131","ending_page":"140","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1182/blood-2007-08-107847"],"issn":["1528-0020"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:16, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377069"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18025150","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215074","label":"url"}],"paper_title":{"en":"Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.","ja":"Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase."},"authors":{"en":[{"name":"Aiba Yuichi"},{"name":"Kameyama Megumi"},{"name":"Yamazaki Tetsuo"},{"name":"Tedder F. Thomas"},{"name":"Kurosaki Tomohiro"}],"ja":[{"name":"Aiba Yuichi"},{"name":"Kameyama Megumi"},{"name":"山﨑 哲男"},{"name":"Tedder F. Thomas"},{"name":"Kurosaki Tomohiro"}]},"description":{"en":"Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cells. The YXXM motifs in BCAP and CD19 are crucial for regulating B-cell development in that mutation of these motifs abrogated their ability to induce BCR-mediated Akt activation as well as to promote B-cell development. Furthermore, the developmental defect in CD19(-/-)BCAP(-/-) B cells was partly relieved by introducing a constitutively active form of PI3K or PDK1. Together, our data suggest that BCAP and CD19 have complementary roles in BCR-mediated PI3K activation, thereby, at least in part, contributing to B-cell development.","ja":"Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cells. The YXXM motifs in BCAP and CD19 are crucial for regulating B-cell development in that mutation of these motifs abrogated their ability to induce BCR-mediated Akt activation as well as to promote B-cell development. Furthermore, the developmental defect in CD19(-/-)BCAP(-/-) B cells was partly relieved by introducing a constitutively active form of PI3K or PDK1. Together, our data suggest that BCAP and CD19 have complementary roles in BCR-mediated PI3K activation, thereby, at least in part, contributing to B-cell development."},"publication_date":"2007-11-19","publication_name":{"en":"Blood","ja":"Blood"},"volume":"Vol.111","number":"No.3","starting_page":"1497","ending_page":"1503","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1182/blood-2007-08-109769"],"issn":["0006-4971"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:17, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377070"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17904530","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215073","label":"url"}],"paper_title":{"en":"Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins.","ja":"Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins."},"authors":{"en":[{"name":"Ikeda Atsushi"},{"name":"Miyazaki Taisuke"},{"name":"Kakizawa Sho"},{"name":"Okuno Yasushi"},{"name":"Tsuchiya Soken"},{"name":"Myomoto Akira"},{"name":"Saito Shin-ya"},{"name":"Yamamoto Tetsuji"},{"name":"Yamazaki Tetsuo"},{"name":"Iino Masamitsu"},{"name":"Tsujimoto Gozoh"},{"name":"Watanabe Masahiko"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Ikeda Atsushi"},{"name":"Miyazaki Taisuke"},{"name":"Kakizawa Sho"},{"name":"Okuno Yasushi"},{"name":"Tsuchiya Soken"},{"name":"Myomoto Akira"},{"name":"Saito Shin-ya"},{"name":"Yamamoto Tetsuji"},{"name":"山﨑 哲男"},{"name":"Iino Masamitsu"},{"name":"Tsujimoto Gozoh"},{"name":"Watanabe Masahiko"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"Junctional membrane complexes (JMCs) generated by junctophilins are required for Ca(2+)-mediated communication between cell-surface and intracellular channels in excitable cells. Knockout mice lacking neural junctophilins (JP-DKO) show severe motor defects and irregular cerebellar plasticity due to abolished channel crosstalk in Purkinje cells (PCs). To precisely understand aberrations in JP-DKO mice, we further analyzed the mutant PCs. During the induction of cerebellar plasticity via electrical stimuli, JP-DKO PCs showed insufficient depolarizing responses. Immunochemistry detected mild impairment in synaptic maturation and hyperphosphorylation of protein kinase Cgamma in JP-DKO PCs. Moreover, gene expression was slightly altered in the JP-DKO cerebellum. Therefore, the mutant PCs bear marginal but widespread abnormalities, all of which likely cause cerebellar motor defects in JP-DKO mice.","ja":"Junctional membrane complexes (JMCs) generated by junctophilins are required for Ca(2+)-mediated communication between cell-surface and intracellular channels in excitable cells. Knockout mice lacking neural junctophilins (JP-DKO) show severe motor defects and irregular cerebellar plasticity due to abolished channel crosstalk in Purkinje cells (PCs). To precisely understand aberrations in JP-DKO mice, we further analyzed the mutant PCs. During the induction of cerebellar plasticity via electrical stimuli, JP-DKO PCs showed insufficient depolarizing responses. Immunochemistry detected mild impairment in synaptic maturation and hyperphosphorylation of protein kinase Cgamma in JP-DKO PCs. Moreover, gene expression was slightly altered in the JP-DKO cerebellum. Therefore, the mutant PCs bear marginal but widespread abnormalities, all of which likely cause cerebellar motor defects in JP-DKO mice."},"publication_date":"2007-09-24","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.363","number":"No.3","starting_page":"835","ending_page":"839","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2007.09.062"],"issn":["0006-291X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:18, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377071"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17765869","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215072","label":"url"}],"paper_title":{"en":"Augmentation of drug-induced cell death by ER protein BRI3BP.","ja":"Augmentation of drug-induced cell death by ER protein BRI3BP."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Sasaki Nozomi"},{"name":"Nishi Miyuki"},{"name":"Yamazaki Daiju"},{"name":"Ikeda Atsushi"},{"name":"Okuno Yasushi"},{"name":"Komazaki Shinji"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"山﨑 哲男"},{"name":"Sasaki Nozomi"},{"name":"Nishi Miyuki"},{"name":"Yamazaki Daiju"},{"name":"Ikeda Atsushi"},{"name":"Okuno Yasushi"},{"name":"Komazaki Shinji"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"To determine the contribution of the endoplasmic reticulum (ER) to cell fate decision, we focused on BRI3-binding protein (BRI3BP) residing in this organelle. BRI3BP, when overexpressed, augmented the apoptosis of human embryonic kidney 293T cells challenged with drugs including the anti-cancer agent etoposide. In contrast, the knockdown of BRI3BP reduced the drug-triggered apoptosis. BRI3BP overexpression enhanced both mitochondrial cytochrome c release and caspase-3 activity in etoposide-treated cells. In response to etoposide, the ER reorganized into irregularly shaped lamellae in mock-transfected cells, whereas in BRI3BP-overexpressing cells, such reorganization was not observed. These observations suggest that BRI3BP is involved in the structural dynamics of the ER and affects mitochondrial viability. Taken together, BRI3BP, widely expressed in animal cell types, seems to possess a pro-apoptotic property and can potentiate drug-induced apoptosis.","ja":"To determine the contribution of the endoplasmic reticulum (ER) to cell fate decision, we focused on BRI3-binding protein (BRI3BP) residing in this organelle. BRI3BP, when overexpressed, augmented the apoptosis of human embryonic kidney 293T cells challenged with drugs including the anti-cancer agent etoposide. In contrast, the knockdown of BRI3BP reduced the drug-triggered apoptosis. BRI3BP overexpression enhanced both mitochondrial cytochrome c release and caspase-3 activity in etoposide-treated cells. In response to etoposide, the ER reorganized into irregularly shaped lamellae in mock-transfected cells, whereas in BRI3BP-overexpressing cells, such reorganization was not observed. These observations suggest that BRI3BP is involved in the structural dynamics of the ER and affects mitochondrial viability. Taken together, BRI3BP, widely expressed in animal cell types, seems to possess a pro-apoptotic property and can potentiate drug-induced apoptosis."},"publication_date":"2007-08-27","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.362","number":"No.4","starting_page":"971","ending_page":"975","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2007.08.082"],"issn":["0006-291X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:19, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377072"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17204322","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215088","label":"url"}],"paper_title":{"en":"Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum.","ja":"Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum."},"authors":{"en":[{"name":"Zhang Miao"},{"name":"Yamazaki Tetsuo"},{"name":"Yazawa Masayuki"},{"name":"Treves Susan"},{"name":"Nishi Miyuki"},{"name":"Murai Machiko"},{"name":"Shibata Eisuke"},{"name":"Zorzato Francesco"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Zhang Miao"},{"name":"山﨑 哲男"},{"name":"Yazawa Masayuki"},{"name":"Treves Susan"},{"name":"Nishi Miyuki"},{"name":"Murai Machiko"},{"name":"Shibata Eisuke"},{"name":"Zorzato Francesco"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"We have identified a novel endoplasmic reticulum (ER)-resident protein, named \"calumin\", which is expressed in various tissues. This protein has a molecular mass of approximately 60 kDa and is composed of an ER-luminal domain rich in acidic residues, a single transmembrane segment, and a large cytoplasmic domain. Biochemical experiments demonstrated that the amino-terminal luminal domain is capable of binding Ca2+ with a high capacity and moderate affinity. In embryonic fibroblasts derived from calumin-knockout mice exhibiting embryonic and neonatal lethality, fluorometric Ca2+ imaging detected insufficient Ca2+ contents in intracellular stores and attenuated store-operated Ca2+ entry. Moreover, the mutant fibroblasts were highly sensitive to cell death induced by ER stress. These observations suggest that calumin plays an essential role in ER Ca2+ handling and is also implicated in signaling from the ER, which is closely associated with cell-fate decision.","ja":"We have identified a novel endoplasmic reticulum (ER)-resident protein, named \"calumin\", which is expressed in various tissues. This protein has a molecular mass of approximately 60 kDa and is composed of an ER-luminal domain rich in acidic residues, a single transmembrane segment, and a large cytoplasmic domain. Biochemical experiments demonstrated that the amino-terminal luminal domain is capable of binding Ca2+ with a high capacity and moderate affinity. In embryonic fibroblasts derived from calumin-knockout mice exhibiting embryonic and neonatal lethality, fluorometric Ca2+ imaging detected insufficient Ca2+ contents in intracellular stores and attenuated store-operated Ca2+ entry. Moreover, the mutant fibroblasts were highly sensitive to cell death induced by ER stress. These observations suggest that calumin plays an essential role in ER Ca2+ handling and is also implicated in signaling from the ER, which is closely associated with cell-fate decision."},"publication_date":"2007-01-03","publication_name":{"en":"Cell Calcium","ja":"Cell Calcium"},"volume":"Vol.42","number":"No.1","starting_page":"83","ending_page":"90","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.ceca.2006.11.009"],"issn":["0143-4160"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:20, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377073"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/16546095","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215087","label":"url"}],"paper_title":{"en":"BANK negatively regulates Akt activation and subsequent B cell responses.","ja":"BANK negatively regulates Akt activation and subsequent B cell responses."},"authors":{"en":[{"name":"Aiba Yuichi"},{"name":"Yamazaki Tetsuo"},{"name":"Okada Takaharu"},{"name":"Gotoh Kumiko"},{"name":"Sanjo Hideki"},{"name":"Ogata Masato"},{"name":"Kurosaki Tomohiro"}],"ja":[{"name":"Aiba Yuichi"},{"name":"山﨑 哲男"},{"name":"Okada Takaharu"},{"name":"Gotoh Kumiko"},{"name":"Sanjo Hideki"},{"name":"Ogata Masato"},{"name":"Kurosaki Tomohiro"}]},"description":{"en":"BANK is an adaptor protein that is highly expressed in B cells. To investigate its physiological role, we generated BANK-deficient mice. BANK-deficient mice displayed enhanced germinal center formation and IgM production in response to T-dependent antigens, whereas this phenotype was blocked in CD40-BANK double knockout mice. Involvement of BANK in CD40 signaling was further demonstrated by in vitro analysis. CD40-mediated proliferation and survival were significantly increased in BANK-deficient B cells, with enhanced Akt activation, whereas introduction of dominant-negative Akt into BANK-deficient B cells suppressed the augmented CD40-mediated responses. Together, our findings suggest that BANK attenuates CD40-mediated Akt activation, thereby preventing hyperactive B cell responses.","ja":"BANK is an adaptor protein that is highly expressed in B cells. To investigate its physiological role, we generated BANK-deficient mice. BANK-deficient mice displayed enhanced germinal center formation and IgM production in response to T-dependent antigens, whereas this phenotype was blocked in CD40-BANK double knockout mice. Involvement of BANK in CD40 signaling was further demonstrated by in vitro analysis. CD40-mediated proliferation and survival were significantly increased in BANK-deficient B cells, with enhanced Akt activation, whereas introduction of dominant-negative Akt into BANK-deficient B cells suppressed the augmented CD40-mediated responses. Together, our findings suggest that BANK attenuates CD40-mediated Akt activation, thereby preventing hyperactive B cell responses."},"publication_date":"2006-03","publication_name":{"en":"Immunity","ja":"Immunity"},"volume":"Vol.24","number":"No.3","starting_page":"259","ending_page":"268","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.immuni.2006.01.002"],"issn":["1074-7613"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:21, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377074"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/12833156","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215086","label":"url"}],"paper_title":{"en":"Contribution of BCAP to maintenance of mature B cells through c-Rel.","ja":"Contribution of BCAP to maintenance of mature B cells through c-Rel."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Kurosaki Tomohiro"}],"ja":[{"name":"山﨑 哲男"},{"name":"Kurosaki Tomohiro"}]},"description":{"en":"Mice deficient in the B cell adaptor for phosphoinositide 3-kinase (BCAP) have reduced numbers of mature B lymphocytes, which show defects in cell survival and proliferation. We found here that the NF-kappa B (Rel) pathway was impaired in BCAP-deficient mature B cells and that NF-kappa B target genes, indispensable for cell survival and division, were not induced in response to B cell receptor (BCR) stimulation. Among the NF-kappa B (Rel) family, expression of c-Rel was specifically reduced in BCAP-deficient B cells. Retrovirus-mediated reintroduction of c-Rel restored the pool size of immunoglobulin (Ig)M(lo)IgD(hi) mature B cells in the spleen as well as proliferative responses to BCR stimulation. These results indicate BCAP is essential in the maintenance of mature B cells through functional coupling with c-Rel.","ja":"Mice deficient in the B cell adaptor for phosphoinositide 3-kinase (BCAP) have reduced numbers of mature B lymphocytes, which show defects in cell survival and proliferation. We found here that the NF-kappa B (Rel) pathway was impaired in BCAP-deficient mature B cells and that NF-kappa B target genes, indispensable for cell survival and division, were not induced in response to B cell receptor (BCR) stimulation. Among the NF-kappa B (Rel) family, expression of c-Rel was specifically reduced in BCAP-deficient B cells. Retrovirus-mediated reintroduction of c-Rel restored the pool size of immunoglobulin (Ig)M(lo)IgD(hi) mature B cells in the spleen as well as proliferative responses to BCR stimulation. These results indicate BCAP is essential in the maintenance of mature B cells through functional coupling with c-Rel."},"publication_date":"2003-06-29","publication_name":{"en":"Nature Immunology","ja":"Nature Immunology"},"volume":"Vol.4","number":"No.8","starting_page":"780","ending_page":"786","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/ni949"],"issn":["1529-2908"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:22, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377075"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/12356870","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215084","label":"url"}],"paper_title":{"en":"T cell receptor ligation induces the formation of dynamically regulated signaling assemblies.","ja":"T cell receptor ligation induces the formation of dynamically regulated signaling assemblies."},"authors":{"en":[{"name":"Bunnell C. Stephen"},{"name":"Hong I. David"},{"name":"Kardon R. Julia"},{"name":"Yamazaki Tetsuo"},{"name":"McGlade Jane C"},{"name":"Barr A. Valarie"},{"name":"Samelson E. Lawrence"}],"ja":[{"name":"Bunnell C. Stephen"},{"name":"Hong I. David"},{"name":"Kardon R. Julia"},{"name":"山﨑 哲男"},{"name":"McGlade Jane C"},{"name":"Barr A. Valarie"},{"name":"Samelson E. Lawrence"}]},"description":{"en":"Tcell antigen receptor (TCR) ligation initiates tyrosine kinase activation, signaling complex assembly, and immune synapse formation. Here, we studied the kinetics and mechanics of signaling complex formation in live Jurkat leukemic T cells using signaling proteins fluorescently tagged with variants of enhanced GFP (EGFP). Within seconds of contacting coverslips coated with stimulatory antibodies, T cells developed small, dynamically regulated clusters which were enriched in the TCR, phosphotyrosine, ZAP-70, LAT, Grb2, Gads, and SLP-76, excluded the lipid raft marker enhanced yellow fluorescent protein-GPI, and were competent to induce calcium elevations. LAT, Grb2, and Gads were transiently associated with the TCR. Although ZAP-70-containing clusters persisted for more than 20 min, photobleaching studies revealed that ZAP-70 continuously dissociated from and returned to these complexes. Strikingly, SLP-76 translocated to a perinuclear structure after clustering with the TCR. Our results emphasize the dynamically changing composition of signaling complexes and indicate that these complexes can form within seconds of TCR engagement, in the absence of either lipid raft aggregation or the formation of a central TCR-rich cluster.","ja":"Tcell antigen receptor (TCR) ligation initiates tyrosine kinase activation, signaling complex assembly, and immune synapse formation. Here, we studied the kinetics and mechanics of signaling complex formation in live Jurkat leukemic T cells using signaling proteins fluorescently tagged with variants of enhanced GFP (EGFP). Within seconds of contacting coverslips coated with stimulatory antibodies, T cells developed small, dynamically regulated clusters which were enriched in the TCR, phosphotyrosine, ZAP-70, LAT, Grb2, Gads, and SLP-76, excluded the lipid raft marker enhanced yellow fluorescent protein-GPI, and were competent to induce calcium elevations. LAT, Grb2, and Gads were transiently associated with the TCR. Although ZAP-70-containing clusters persisted for more than 20 min, photobleaching studies revealed that ZAP-70 continuously dissociated from and returned to these complexes. Strikingly, SLP-76 translocated to a perinuclear structure after clustering with the TCR. Our results emphasize the dynamically changing composition of signaling complexes and indicate that these complexes can form within seconds of TCR engagement, in the absence of either lipid raft aggregation or the formation of a central TCR-rich cluster."},"publication_date":"2002-09-30","publication_name":{"en":"The Journal of Cell Biology","ja":"The Journal of Cell Biology"},"volume":"Vol.158","number":"No.7","starting_page":"1263","ending_page":"1275","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1083/jcb.200203043"],"issn":["0021-9525"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:23, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377076"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/11956311","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215083","label":"url"}],"paper_title":{"en":"Role of Grb2 in EGF-stimulated EGFR internalization.","ja":"Role of Grb2 in EGF-stimulated EGFR internalization."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Zaal Kristien"},{"name":"Hailey Dale"},{"name":"Presley John"},{"name":"Lippincott-Schwartz Jennifer"},{"name":"Samelson E. Lawrence"}],"ja":[{"name":"山﨑 哲男"},{"name":"Zaal Kristien"},{"name":"Hailey Dale"},{"name":"Presley John"},{"name":"Lippincott-Schwartz Jennifer"},{"name":"Samelson E. Lawrence"}]},"description":{"en":"Grb2 is an adaptor molecule that couples membrane receptors such as the epidermal growth factor receptor (EGFR) to intracellular signaling pathways. To gain insight into the trafficking pathways followed by these molecules after activation by EGF, we visualized Grb2 and EGFR fused to GFP spectral variants in single live cells. In nonstimulated cells, Grb2-YFP was primarily localized diffusely in the cytoplasm, whereas EGFR-CFP was found on the plasma membrane and in endocytic structures localized in the perinuclear area. Within 1 minute of EGF stimulation, Grb2 redistributed to the plasma membrane where it bound EGFR-CFP in an SH2 dependent manner. The plasma membrane then began to dynamically ruffle, and Grb2-YFP and EGFR-CFP were found to internalize together in large macropinocytic structures. These structures were morphologically distinct from conventional, clathrin-derived endosomes and did not label with transferrin, AP-2 or clathrin heavy chain. Evidence that these structures did not require clathrin for internalization came from experiments showing that expression of the C-terminus of AP-180, which inhibited transferrin uptake, had no effect on EGF-induced internalization of EGFR. YFP-tagged Grb2 containing an inhibitory mutation in either N- or C-SH3 domain redistributed to the plasma membrane upon EGF stimulation, but the macropinocytic structures containing Grb2-YFP and EGFR-CFP did not translocate inward and appeared to remain tethered to the plasma membrane. This suggested that the Grb2 SH3 domain was responsible for coupling the membranes containing EGFR with downstream effectors involved in internalization of these membranes. Transferrin uptake was unaffected in the presence of all of the SH3 domain mutants, consistent with the EGF-stimulated EGFR internalization pathway being clathrin-independent. These results demonstrate a role for Grb2 in events associated with a macropinocytic internalization pathway for EGFR in activated cells.","ja":"Grb2 is an adaptor molecule that couples membrane receptors such as the epidermal growth factor receptor (EGFR) to intracellular signaling pathways. To gain insight into the trafficking pathways followed by these molecules after activation by EGF, we visualized Grb2 and EGFR fused to GFP spectral variants in single live cells. In nonstimulated cells, Grb2-YFP was primarily localized diffusely in the cytoplasm, whereas EGFR-CFP was found on the plasma membrane and in endocytic structures localized in the perinuclear area. Within 1 minute of EGF stimulation, Grb2 redistributed to the plasma membrane where it bound EGFR-CFP in an SH2 dependent manner. The plasma membrane then began to dynamically ruffle, and Grb2-YFP and EGFR-CFP were found to internalize together in large macropinocytic structures. These structures were morphologically distinct from conventional, clathrin-derived endosomes and did not label with transferrin, AP-2 or clathrin heavy chain. Evidence that these structures did not require clathrin for internalization came from experiments showing that expression of the C-terminus of AP-180, which inhibited transferrin uptake, had no effect on EGF-induced internalization of EGFR. YFP-tagged Grb2 containing an inhibitory mutation in either N- or C-SH3 domain redistributed to the plasma membrane upon EGF stimulation, but the macropinocytic structures containing Grb2-YFP and EGFR-CFP did not translocate inward and appeared to remain tethered to the plasma membrane. This suggested that the Grb2 SH3 domain was responsible for coupling the membranes containing EGFR with downstream effectors involved in internalization of these membranes. Transferrin uptake was unaffected in the presence of all of the SH3 domain mutants, consistent with the EGF-stimulated EGFR internalization pathway being clathrin-independent. These results demonstrate a role for Grb2 in events associated with a macropinocytic internalization pathway for EGFR in activated cells."},"publication_date":"2002-05-01","publication_name":{"en":"Journal of Cell Science","ja":"Journal of Cell Science"},"volume":"Vol.115","number":"No.Pt 9","starting_page":"1791","ending_page":"1802","languages":["eng"],"referee":true,"identifiers":{"issn":["0021-9533"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:24, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377077"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/11877477","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-0037018096&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215081","label":"url"}],"paper_title":{"en":"Essential immunoregulatory role for BCAP in B cell development and function.","ja":"Essential immunoregulatory role for BCAP in B cell development and function."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Takeda Kiyoshi"},{"name":"Gotoh Kumiko"},{"name":"Takeshima Hiroshi"},{"name":"Akira Shizuo"},{"name":"Kurosaki Tomohiro"}],"ja":[{"name":"山﨑 哲男"},{"name":"Takeda Kiyoshi"},{"name":"Gotoh Kumiko"},{"name":"Takeshima Hiroshi"},{"name":"Akira Shizuo"},{"name":"Kurosaki Tomohiro"}]},"description":{"en":"BCAP was recently cloned as a binding molecule to phosphoinositide 3-kinase (PI3K). To investigate the role of BCAP, mutant mice deficient in BCAP were generated. While BCAP-deficient mice are viable, they have decreased numbers of mature B cells and B1 B cell deficiency. The mice produce lower titers of serum immunoglobulin (Ig)M and IgG3, and mount attenuated responses to T cell--independent type II antigen. Upon B cell receptor cross-linking, BCAP-deficient B cells exhibit reduced Ca(2+) mobilization and poor proliferative responses. These findings demonstrate that BCAP plays a pivotal immunoregulatory role in B cell development and humoral immune responses.","ja":"BCAP was recently cloned as a binding molecule to phosphoinositide 3-kinase (PI3K). To investigate the role of BCAP, mutant mice deficient in BCAP were generated. While BCAP-deficient mice are viable, they have decreased numbers of mature B cells and B1 B cell deficiency. The mice produce lower titers of serum immunoglobulin (Ig)M and IgG3, and mount attenuated responses to T cell--independent type II antigen. Upon B cell receptor cross-linking, BCAP-deficient B cells exhibit reduced Ca(2+) mobilization and poor proliferative responses. These findings demonstrate that BCAP plays a pivotal immunoregulatory role in B cell development and humoral immune responses."},"publication_date":"2002-03-04","publication_name":{"en":"The Journal of Experimental Medicine","ja":"The Journal of Experimental Medicine"},"volume":"Vol.195","number":"No.5","starting_page":"535","ending_page":"545","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1084/jem.20011751"],"issn":["0022-1007"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:25, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377078"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/10373416","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287681","label":"url"}],"paper_title":{"en":"CAST, a novel CD3epsilon-binding protein transducing activation signal for interleukin-2 production in T cells.","ja":"CAST, a novel CD3epsilon-binding protein transducing activation signal for interleukin-2 production in T cells."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Hamano Y"},{"name":"Tashiro H"},{"name":"Itoh K"},{"name":"Nakano H"},{"name":"Miyatake S"},{"name":"Saito T"}],"ja":[{"name":"山﨑 哲男"},{"name":"Hamano Y"},{"name":"Tashiro H"},{"name":"Itoh K"},{"name":"Nakano H"},{"name":"Miyatake S"},{"name":"Saito T"}]},"description":{"en":"Antigen recognition through T cell receptor (TCR)-CD3 complex transduces signals into T cells, which regulate activation, function, and differentiation of T cells. The TCR-CD3 complex is composed of two signaling modules represented by CD3zeta and CD3epsilon. Signaling through CD3zeta has been extensively analyzed, but that via CD3epsilon, which is also crucial in immature thymocyte development, is still not clearly understood. We isolated cDNA encoding a novel CD3epsilon-binding protein CAST. CAST specifically interacts in vivo and in vitro with CD3epsilon but not with CD3zeta or FcRgamma via a unique membrane-proximal region of CD3epsilon. CAST is composed of 512 amino acids including a single tyrosine and undergoes tyrosine phosphorylation upon TCR stimulation. Overexpression of two dominant-negative types of CAST, a minimum CD3epsilon-binding domain and a tyrosine-mutant, strongly suppressed NFAT activation and interleukin-2 production. These results demonstrate that CAST serves as a component of preformed TCR complex and transduces activation signals upon TCR stimulation and represents a new signaling pathway via the CD3epsilon-containing TCR signaling module.","ja":"Antigen recognition through T cell receptor (TCR)-CD3 complex transduces signals into T cells, which regulate activation, function, and differentiation of T cells. The TCR-CD3 complex is composed of two signaling modules represented by CD3zeta and CD3epsilon. Signaling through CD3zeta has been extensively analyzed, but that via CD3epsilon, which is also crucial in immature thymocyte development, is still not clearly understood. We isolated cDNA encoding a novel CD3epsilon-binding protein CAST. CAST specifically interacts in vivo and in vitro with CD3epsilon but not with CD3zeta or FcRgamma via a unique membrane-proximal region of CD3epsilon. CAST is composed of 512 amino acids including a single tyrosine and undergoes tyrosine phosphorylation upon TCR stimulation. Overexpression of two dominant-negative types of CAST, a minimum CD3epsilon-binding domain and a tyrosine-mutant, strongly suppressed NFAT activation and interleukin-2 production. These results demonstrate that CAST serves as a component of preformed TCR complex and transduces activation signals upon TCR stimulation and represents a new signaling pathway via the CD3epsilon-containing TCR signaling module."},"publication_date":"1999-06-25","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.274","number":"No.26","starting_page":"18173","ending_page":"18180","languages":["eng"],"referee":true,"identifiers":{"issn":["0021-9258"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:26, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377079"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/11232294","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287686","label":"url"}],"paper_title":{"en":"Studies on the adapter molecule LAT.","ja":"Studies on the adapter molecule LAT."},"authors":{"en":[{"name":"Samelson L E"},{"name":"Bunnell S C"},{"name":"Trible R P"},{"name":"Yamazaki Tetsuo"},{"name":"Zhang W"}],"ja":[{"name":"Samelson L E"},{"name":"Bunnell S C"},{"name":"Trible R P"},{"name":"山﨑 哲男"},{"name":"Zhang W"}]},"publication_date":"1999","publication_name":{"en":"Cold Spring Harbor Symposia on Quantitative Biology","ja":"Cold Spring Harbor Symposia on Quantitative Biology"},"volume":"Vol.64","starting_page":"259","ending_page":"263","languages":["eng"],"referee":true,"identifiers":{"issn":["0091-7451"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:27, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377080"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/9813084","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287683","label":"url"}],"paper_title":{"en":"ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulation.","ja":"ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulation."},"authors":{"en":[{"name":"Sloan-Lancaster J"},{"name":"Presley J"},{"name":"Ellenberg J"},{"name":"Yamazaki Tetsuo"},{"name":"Lippincott-Schwartz J"},{"name":"Samelson L E"}],"ja":[{"name":"Sloan-Lancaster J"},{"name":"Presley J"},{"name":"Ellenberg J"},{"name":"山﨑 哲男"},{"name":"Lippincott-Schwartz J"},{"name":"Samelson L E"}]},"description":{"en":"The nonreceptor protein tyrosine kinase ZAP-70 is a critical enzyme required for successful T lymphocyte activation. After antigenic stimulation, ZAP-70 rapidly associates with T cell receptor (TCR) subunits. The kinetics of its translocation to the cell surface, the properties of its specific interaction with the TCRzeta chain expressed as a chimeric protein (TTzeta and Tzetazeta), and its mobility in different intracellular compartments were studied in individual live HeLa cells, using ZAP-70 and Tzetazeta fused to green fluorescent protein (ZAP-70 GFP and Tzetazeta-GFP, respectively). Time-lapse imaging using confocal microscopy indicated that the activation-induced redistribution of ZAP-70 to the plasma membrane, after a delayed onset, is of long duration. The presence of the TCRzeta chain is critical for the redistribution, which is enhanced when an active form of the protein tyrosine kinase Lck is coexpressed. Binding specificity to TTzeta was indicated using mutant ZAP-70 GFPs and a truncated zeta chimera. Photobleaching techniques revealed that ZAP-70 GFP has decreased mobility at the plasma membrane, in contrast to its rapid mobility in the cytosol and nucleus. Tzetazeta- GFP is relatively immobile, while peripherally located ZAP-70 in stimulated cells is less mobile than cytosolic ZAP-70 in unstimulated cells, a phenotype confirmed by determining the respective diffusion constants. Examination of the specific molecular association of signaling proteins using these approaches has provided new insights into the TCRzeta-ZAP-70 interaction and will be a powerful tool for continuing studies of lymphocyte activation.","ja":"The nonreceptor protein tyrosine kinase ZAP-70 is a critical enzyme required for successful T lymphocyte activation. After antigenic stimulation, ZAP-70 rapidly associates with T cell receptor (TCR) subunits. The kinetics of its translocation to the cell surface, the properties of its specific interaction with the TCRzeta chain expressed as a chimeric protein (TTzeta and Tzetazeta), and its mobility in different intracellular compartments were studied in individual live HeLa cells, using ZAP-70 and Tzetazeta fused to green fluorescent protein (ZAP-70 GFP and Tzetazeta-GFP, respectively). Time-lapse imaging using confocal microscopy indicated that the activation-induced redistribution of ZAP-70 to the plasma membrane, after a delayed onset, is of long duration. The presence of the TCRzeta chain is critical for the redistribution, which is enhanced when an active form of the protein tyrosine kinase Lck is coexpressed. Binding specificity to TTzeta was indicated using mutant ZAP-70 GFPs and a truncated zeta chimera. Photobleaching techniques revealed that ZAP-70 GFP has decreased mobility at the plasma membrane, in contrast to its rapid mobility in the cytosol and nucleus. Tzetazeta- GFP is relatively immobile, while peripherally located ZAP-70 in stimulated cells is less mobile than cytosolic ZAP-70 in unstimulated cells, a phenotype confirmed by determining the respective diffusion constants. Examination of the specific molecular association of signaling proteins using these approaches has provided new insights into the TCRzeta-ZAP-70 interaction and will be a powerful tool for continuing studies of lymphocyte activation."},"publication_date":"1998-11-02","publication_name":{"en":"The Journal of Cell Biology","ja":"The Journal of Cell Biology"},"volume":"Vol.143","number":"No.3","starting_page":"613","ending_page":"624","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1083/jcb.143.3.613"],"issn":["0021-9525"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:28, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377081"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/9739057","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287685","label":"url"}],"paper_title":{"en":"Resistance of Fc receptor- deficient mice to fatal glomerulonephritis.","ja":"Resistance of Fc receptor- deficient mice to fatal glomerulonephritis."},"authors":{"en":[{"name":"Park S Y"},{"name":"Ueda S"},{"name":"Ohno H"},{"name":"Hamano Y"},{"name":"Tanaka M"},{"name":"Shiratori T"},{"name":"Yamazaki Tetsuo"},{"name":"Arase H"},{"name":"Arase N"},{"name":"Karasawa A"},{"name":"Sato S"},{"name":"Ledermann B"},{"name":"Kondo Y"},{"name":"Okumura K"},{"name":"Ra C"},{"name":"Saito T"}],"ja":[{"name":"Park S Y"},{"name":"Ueda S"},{"name":"Ohno H"},{"name":"Hamano Y"},{"name":"Tanaka M"},{"name":"Shiratori T"},{"name":"山﨑 哲男"},{"name":"Arase H"},{"name":"Arase N"},{"name":"Karasawa A"},{"name":"Sato S"},{"name":"Ledermann B"},{"name":"Kondo Y"},{"name":"Okumura K"},{"name":"Ra C"},{"name":"Saito T"}]},"description":{"en":"Immune complex-mediated inflammation is a common mechanism of various autoimmune diseases. Glomerulonephritis (GN) is one of these diseases, and the main mechanism of the induction of GN has been unclear. We examined the contribution of Fc receptors in the induction of nephrotoxic GN by establishing and analyzing mice deficient in the Fc receptor gamma chain (FcRgamma). Whereas all wild-type mice died from severe glomerulonephritis with hypernitremia by administration of anti-glomerular basement membrane (GBM) antibodies, all FcRgamma-deficient mice survived. Histologically, wild-type mice showed glomerular hypercellularity and thrombotic changes, whereas the renal tissue in FcRgamma-deficient mice was almost intact. Deposition of anti-GBM antibody as well as complement components in the GBM were equally observed in both wild-type and knockout mice. These results demonstrate that the triggering of this type of glomerulonephritis is completely dependent on FcR+ cells.","ja":"Immune complex-mediated inflammation is a common mechanism of various autoimmune diseases. Glomerulonephritis (GN) is one of these diseases, and the main mechanism of the induction of GN has been unclear. We examined the contribution of Fc receptors in the induction of nephrotoxic GN by establishing and analyzing mice deficient in the Fc receptor gamma chain (FcRgamma). Whereas all wild-type mice died from severe glomerulonephritis with hypernitremia by administration of anti-glomerular basement membrane (GBM) antibodies, all FcRgamma-deficient mice survived. Histologically, wild-type mice showed glomerular hypercellularity and thrombotic changes, whereas the renal tissue in FcRgamma-deficient mice was almost intact. Deposition of anti-GBM antibody as well as complement components in the GBM were equally observed in both wild-type and knockout mice. These results demonstrate that the triggering of this type of glomerulonephritis is completely dependent on FcR+ cells."},"publication_date":"1998-09-15","publication_name":{"en":"The Journal of Clinical Investigation","ja":"The Journal of Clinical Investigation"},"volume":"Vol.102","number":"No.6","starting_page":"1229","ending_page":"1238","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1172/JCI3256"],"issn":["0021-9738"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:29, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377082"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/9029099","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287684","label":"url"}],"paper_title":{"en":"A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice.","ja":"A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice."},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Arase H"},{"name":"Ono S"},{"name":"Ohno H"},{"name":"Watanabe H"},{"name":"Saito T"}],"ja":[{"name":"山﨑 哲男"},{"name":"Arase H"},{"name":"Ono S"},{"name":"Ohno H"},{"name":"Watanabe H"},{"name":"Saito T"}]},"description":{"en":"T cell selection is thought to be determined through the interaction between TCR and Ag/MHC. However, the contribution of the level of TCR signal to thymic selection remains unclear. To address this issue, we analyzed T cell selection of male Ag (HY)-specific TCR transgenic (HYTg) mice crossed with CD3 zeta-deficient (zeta KO) mice (HYTg/zeta KO), which have impaired signaling through TCR. In male HYTg/zeta KO mice, the number of thymocytes was comparable to that in normal mice, and almost all the peripheral T cells were HY specific, although these positively selected cells were anergic to male Ag. From these observations, the decrease in TCR signaling by CD3 zeta deficiency resulted in both the avoidance of negative selection and the acquisition of positive selection of autoreactive T cells in male HYTg/zeta KO mice. There was a shift of T cell selection from positive to no selection of HY-specific T cells in female HYTg/zeta KO mice also. Collectively, these findings suggest that the level of TCR signal directly regulates T cell selection; furthermore, the findings have integrated the models of T cell selection into a concept based on the quantity of TCR signal.","ja":"T cell selection is thought to be determined through the interaction between TCR and Ag/MHC. However, the contribution of the level of TCR signal to thymic selection remains unclear. To address this issue, we analyzed T cell selection of male Ag (HY)-specific TCR transgenic (HYTg) mice crossed with CD3 zeta-deficient (zeta KO) mice (HYTg/zeta KO), which have impaired signaling through TCR. In male HYTg/zeta KO mice, the number of thymocytes was comparable to that in normal mice, and almost all the peripheral T cells were HY specific, although these positively selected cells were anergic to male Ag. From these observations, the decrease in TCR signaling by CD3 zeta deficiency resulted in both the avoidance of negative selection and the acquisition of positive selection of autoreactive T cells in male HYTg/zeta KO mice. There was a shift of T cell selection from positive to no selection of HY-specific T cells in female HYTg/zeta KO mice also. Collectively, these findings suggest that the level of TCR signal directly regulates T cell selection; furthermore, the findings have integrated the models of T cell selection into a concept based on the quantity of TCR signal."},"publication_date":"1997-02-15","publication_name":{"en":"The Journal of Immunology","ja":"The Journal of Immunology"},"volume":"Vol.158","number":"No.4","starting_page":"1634","ending_page":"1640","languages":["eng"],"referee":true,"identifiers":{"issn":["0022-1767"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:30, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377083"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/8626450","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287679","label":"url"}],"paper_title":{"en":"Specific interaction of topoisomerase II beta and the CD3 epsilon chain of the T cell receptor complex.","ja":"Specific interaction of topoisomerase II beta and the CD3 epsilon chain of the T cell receptor complex."},"authors":{"en":[{"name":"Nakano H"},{"name":"Yamazaki Tetsuo"},{"name":"Miyatake S"},{"name":"Nozaki N"},{"name":"Kikuchi A"},{"name":"Saito T"}],"ja":[{"name":"Nakano H"},{"name":"山﨑 哲男"},{"name":"Miyatake S"},{"name":"Nozaki N"},{"name":"Kikuchi A"},{"name":"Saito T"}]},"description":{"en":"T cell antigen receptor (TCR)-CD3 complex is composed of six different subunits: TCR alpha and TCR beta and CD3 gamma, CD3 delta, CD3 epsilon, and CD3 eta. Antigen recognition signals are transduced from TCR to the cytoplasm through the cytoplasmic domain of the CD3 chains. To understand the downstream signal transduction pathways, we cloned genes encoding proteins capable of binding to CD3 epsilon with a probe of glutathione S-transferase fused to the cytoplasmic region of CD3 epsilon. One of these clones was found to encode topoisomerase II beta (topoII beta). The binding region of CD3 epsilon is located within the N-terminal 12 amino acids containing the motif of a basic amino acid cluster. A similar motif was found in the gamma chain of Fc receptors (FcR gamma) but not in the CD33 eta chain, and indeed, FcR gamma but not CD3 eta bound to topoII beta. The binding region of topoII beta was determined to be the C terminus. Since this region appears to be the regulatory region of the enzymatic activity, the binding of CD3 epsilon might affect the function of topoII beta. Although topoII beta is localized mainly in the nucleus and CD3E is a membrane protein, we demonstrated the presence of CD3 epsilon in the nuclear fraction of thymocytes, which increased upon T cell activation. The specific interaction in cells was evidenced by co-immunoprecipitation of topoII beta and CD3E from the nuclear fraction of T cells. The possible function of this interaction is discussed.","ja":"T cell antigen receptor (TCR)-CD3 complex is composed of six different subunits: TCR alpha and TCR beta and CD3 gamma, CD3 delta, CD3 epsilon, and CD3 eta. Antigen recognition signals are transduced from TCR to the cytoplasm through the cytoplasmic domain of the CD3 chains. To understand the downstream signal transduction pathways, we cloned genes encoding proteins capable of binding to CD3 epsilon with a probe of glutathione S-transferase fused to the cytoplasmic region of CD3 epsilon. One of these clones was found to encode topoisomerase II beta (topoII beta). The binding region of CD3 epsilon is located within the N-terminal 12 amino acids containing the motif of a basic amino acid cluster. A similar motif was found in the gamma chain of Fc receptors (FcR gamma) but not in the CD33 eta chain, and indeed, FcR gamma but not CD3 eta bound to topoII beta. The binding region of topoII beta was determined to be the C terminus. Since this region appears to be the regulatory region of the enzymatic activity, the binding of CD3 epsilon might affect the function of topoII beta. Although topoII beta is localized mainly in the nucleus and CD3E is a membrane protein, we demonstrated the presence of CD3 epsilon in the nuclear fraction of thymocytes, which increased upon T cell activation. The specific interaction in cells was evidenced by co-immunoprecipitation of topoII beta and CD3E from the nuclear fraction of T cells. The possible function of this interaction is discussed."},"publication_date":"1996-03-15","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.271","number":"No.11","starting_page":"6483","ending_page":"6489","languages":["eng"],"referee":true,"identifiers":{"issn":["0021-9258"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:31, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377084"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/7629502","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287680","label":"url"}],"paper_title":{"en":"Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.","ja":"Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas."},"authors":{"en":[{"name":"Miyatake S"},{"name":"Nakano H"},{"name":"Park S Y"},{"name":"Yamazaki Tetsuo"},{"name":"Takase K"},{"name":"Matsushime H"},{"name":"Kato A"},{"name":"Saito T"}],"ja":[{"name":"Miyatake S"},{"name":"Nakano H"},{"name":"Park S Y"},{"name":"山﨑 哲男"},{"name":"Takase K"},{"name":"Matsushime H"},{"name":"Kato A"},{"name":"Saito T"}]},"description":{"en":"The relationship between activation-induced growth inhibition and regulation of the cell cycle progression was investigated in T cell hybridomas by studying the function of the cell cycle-regulating genes such as G1 cyclins and their associated kinases. Activation of T cell hybridomas by anti-T cell receptor antibody induces growth arrest at G1 phase of the cell cycle and subsequently results in activation-driven cell death. Rapid reduction of both messenger RNA and protein level of the cyclin D3 is accompanied by growth arrest upon activation. Although the residual cyclin D3 protein forms a complex with cdk4 protein, cyclin D3-dependent kinase activity is severely impaired. Stable transfectants engineered to express cyclin D3 override the growth arrest upon activation. These results imply that the activation signal through T cell receptor induces the down-regulation of cyclin D3 expression and cyclin D3-dependent kinase activity, leading to growth arrest in G1 phase of the cell cycle in T cells.","ja":"The relationship between activation-induced growth inhibition and regulation of the cell cycle progression was investigated in T cell hybridomas by studying the function of the cell cycle-regulating genes such as G1 cyclins and their associated kinases. Activation of T cell hybridomas by anti-T cell receptor antibody induces growth arrest at G1 phase of the cell cycle and subsequently results in activation-driven cell death. Rapid reduction of both messenger RNA and protein level of the cyclin D3 is accompanied by growth arrest upon activation. Although the residual cyclin D3 protein forms a complex with cdk4 protein, cyclin D3-dependent kinase activity is severely impaired. Stable transfectants engineered to express cyclin D3 override the growth arrest upon activation. These results imply that the activation signal through T cell receptor induces the down-regulation of cyclin D3 expression and cyclin D3-dependent kinase activity, leading to growth arrest in G1 phase of the cell cycle in T cells."},"publication_date":"1995-08-01","publication_name":{"en":"The Journal of Experimental Medicine","ja":"The Journal of Experimental Medicine"},"volume":"Vol.182","number":"No.2","starting_page":"401","ending_page":"408","languages":["eng"],"referee":true,"identifiers":{"issn":["0022-1007"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:32, {"insert":{"user_id":"R000010784","type":"published_papers","id":"30377085"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/8127699","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287682","label":"url"}],"paper_title":{"en":"Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202.","ja":"Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202."},"authors":{"en":[{"name":"Nakano H"},{"name":"Yamazaki Tetsuo"},{"name":"Ikeda M"},{"name":"Masai H"},{"name":"Miyatake S"},{"name":"Saito T"}],"ja":[{"name":"Nakano H"},{"name":"山﨑 哲男"},{"name":"Ikeda M"},{"name":"Masai H"},{"name":"Miyatake S"},{"name":"Saito T"}]},"publication_date":"1994-02-11","publication_name":{"en":"Nucleic Acids Research","ja":"Nucleic Acids Research"},"volume":"Vol.22","number":"No.3","starting_page":"543","ending_page":"544","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/nar/22.3.543"],"issn":["0305-1048"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:33, {"insert":{"user_id":"R000010784","type":"published_papers","id":"45575840"},"force":{"see_also":[{"@id":"https://www.sciencedirect.com/science/article/pii/S1096719223006741?via%3Dihub","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405054","label":"url"}],"paper_title":{"en":"CTSD integrity in the endoplasmic reticulum is required for CLN6's anti-aggregate activity","ja":"CTSD integrity in the endoplasmic reticulum is required for CLN6's anti-aggregate activity"},"authors":{"en":[{"name":"Yuki Shiro"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"publication_date":"2024-02","publication_name":{"en":"Molecular Genetics and Metabolism","ja":"Molecular Genetics and Metabolism"},"volume":"Vol.141","number":"No.2","starting_page":"108044","ending_page":"108044","languages":["eng"],"identifiers":{"doi":["10.1016/j.ymgme.2023.108044"],"issn":["1096-7206"]},"published_paper_type":"research_institution"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/published_papers.jsonl, dLbjho4BzHGxATo5TjtC) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/misc.jsonl) ==== line:1, {"insert":{"user_id":"R000010784","type":"misc","id":"36260686"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1520294429647353216/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=384000","label":"url"}],"paper_title":{"en":"運動療法とロボティクスの動向―近未来予測―. 筋ジストロフィーの診療・リハビリテーション医療の動向","ja":"運動療法とロボティクスの動向―近未来予測―. 筋ジストロフィーの診療・リハビリテーション医療の動向"},"authors":{"en":[{"name":"Takata Shinjiro"},{"name":"森脇 好乃美"},{"name":"森脇 笙"},{"name":"馬渕 勝"},{"name":"岩田 織江"},{"name":"国重 裕二"},{"name":"澤田 侑樹"},{"name":"吉兼 麻木子"},{"name":"宮崎 達志"},{"name":"近藤 梨恵子"},{"name":"渡邊 典子"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"髙田 信二郎"},{"name":"森脇 好乃美"},{"name":"森脇 笙"},{"name":"馬渕 勝"},{"name":"岩田 織江"},{"name":"国重 裕二"},{"name":"澤田 侑樹"},{"name":"吉兼 麻木子"},{"name":"宮崎 達志"},{"name":"近藤 梨恵子"},{"name":"渡邊 典子"},{"name":"山﨑 哲男"}]},"publication_date":"2022-01-27","publication_name":{"en":"Journal of Clinical Rehabilitation","ja":"Journal of Clinical Rehabilitation"},"volume":"Vol.31","number":"No.2","starting_page":"134","ending_page":"142","languages":["jpn"],"identifiers":{"issn":["0918-5259"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"R000010784","type":"misc","id":"33312369"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1523951030943292672/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378585","label":"url"}],"paper_title":{"en":"大腿骨近位部骨折回避のための転倒予防の重要性と具体策 : サルコペニアとフレイルからのアプローチを含む (第47回 日本股関節学会学術集会 シンポジウム2 大腿骨近位部骨折の予防と治療における新たな知見と進歩を目指して)","ja":"大腿骨近位部骨折回避のための転倒予防の重要性と具体策 : サルコペニアとフレイルからのアプローチを含む (第47回 日本股関節学会学術集会 シンポジウム2 大腿骨近位部骨折の予防と治療における新たな知見と進歩を目指して)"},"authors":{"en":[{"name":"Takata Shinjiro"},{"name":"森脇 笙"},{"name":"Ueda Yuka"},{"name":"元木 由美"},{"name":"森脇 好乃美"},{"name":"Yamazaki Tetsuo"},{"name":"田村 英司"},{"name":"住友 祐介"},{"name":"柿本 直子"},{"name":"海部 忍"}],"ja":[{"name":"髙田 信二郎"},{"name":"森脇 笙"},{"name":"上田 由佳"},{"name":"元木 由美"},{"name":"森脇 好乃美"},{"name":"山﨑 哲男"},{"name":"田村 英司"},{"name":"住友 祐介"},{"name":"柿本 直子"},{"name":"海部 忍"}]},"publication_date":"2021-02","publication_name":{"en":"The Journal of Japan Osteoporosis Society","ja":"日本骨粗鬆症学会雑誌"},"volume":"Vol.7","number":"No.2","starting_page":"358","ending_page":"363","languages":["jpn"],"identifiers":{"issn":["2189-8383"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"R000010784","type":"misc","id":"30377086"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/10026299722/","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19999584","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1520009407923877120/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215080","label":"url"}],"paper_title":{"en":"Physiological functions of TRIC channels","ja":"TRICチャネルの生理的機能"},"authors":{"en":[{"name":"Yamazaki Daiju"},{"name":"Yamazaki Tetsuo"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Yamazaki Daiju"},{"name":"山﨑 哲男"},{"name":"Takeshima Hiroshi"}]},"publication_date":"2009-11-25","publication_name":{"en":"Seikagaku","ja":"生化学"},"volume":"Vol.81","number":"No.11","starting_page":"1004","ending_page":"1008","languages":["jpn"],"identifiers":{"issn":["0037-1017"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"R000010784","type":"misc","id":"30377087"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19095005","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215077","label":"url"}],"paper_title":{"en":"New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.","ja":"New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes."},"authors":{"en":[{"name":"Yamazaki Daiju"},{"name":"Yamazaki Tetsuo"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Yamazaki Daiju"},{"name":"山﨑 哲男"},{"name":"Takeshima Hiroshi"}]},"description":{"en":"Ca(2+) mobilization from intracellular stores is mediated by Ca(2+) release channels, designated ryanodine and IP(3) receptors, and directly regulates important cellular reactions including muscle contraction, endo/exocrine secretion, and neural excitability. In order to function as an intracellular store, the endo/sarcoplasmic reticulum is equipped with cooperative Ca(2+) uptake, storage and release machineries, comprising synergic collaborations among integral-membrane, cytoplasmic and luminal proteins. Our recent studies have demonstrated that junctophilins form junctional membrane complexes between the plasma membrane and the endo/sarcoplasmic reticulum in excitable cells, and that TRIC (trimeric intracellular cation) channels act as novel monovalent cation-specific channels on intracellular membrane systems. Knockout mice have provided evidence that both junctophilins and TRIC channels support efficient ryanodine receptor-mediated Ca(2+) release in muscle cells. This review focuses on cardiac Ca(2+) release by discussing pathological defects of mutant cardiomyocytes lacking ryanodine receptors, junctophilins, or TRIC channels.","ja":"Ca(2+) mobilization from intracellular stores is mediated by Ca(2+) release channels, designated ryanodine and IP(3) receptors, and directly regulates important cellular reactions including muscle contraction, endo/exocrine secretion, and neural excitability. In order to function as an intracellular store, the endo/sarcoplasmic reticulum is equipped with cooperative Ca(2+) uptake, storage and release machineries, comprising synergic collaborations among integral-membrane, cytoplasmic and luminal proteins. Our recent studies have demonstrated that junctophilins form junctional membrane complexes between the plasma membrane and the endo/sarcoplasmic reticulum in excitable cells, and that TRIC (trimeric intracellular cation) channels act as novel monovalent cation-specific channels on intracellular membrane systems. Knockout mice have provided evidence that both junctophilins and TRIC channels support efficient ryanodine receptor-mediated Ca(2+) release in muscle cells. This review focuses on cardiac Ca(2+) release by discussing pathological defects of mutant cardiomyocytes lacking ryanodine receptors, junctophilins, or TRIC channels."},"publication_date":"2008-12-03","publication_name":{"en":"Pharmacology & Therapeutics","ja":"Pharmacology & Therapeutics"},"volume":"Vol.121","number":"No.3","starting_page":"265","ending_page":"272","languages":["eng"],"identifiers":{"doi":["10.1016/j.pharmthera.2008.11.004"],"issn":["0163-7258"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"R000010784","type":"misc","id":"30377088"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1524232505734459136/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378568","label":"url"}],"paper_title":{"en":"Molecular basis of ryanodine receptor-mediated Ca[2+] release","ja":"リアノジン受容体による小胞体Ca[2+]放出の分子機構"},"authors":{"en":[{"name":"池田 篤史"},{"name":"Yamazaki Tetsuo"},{"name":"竹島 浩"}],"ja":[{"name":"池田 篤史"},{"name":"山﨑 哲男"},{"name":"竹島 浩"}]},"publication_date":"2007-12","publication_name":{"en":"Tanpakushitsu Kakusan Koso","ja":"蛋白質 核酸 酵素"},"volume":"Vol.52","number":"No.15","starting_page":"1965","ending_page":"1972","languages":["jpn"],"identifiers":{"issn":["0039-9450"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"R000010784","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18064887","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215075","label":"url"}],"paper_title":{"en":"[Molecular basis of ryanodine receptor-mediated Ca2+ release]","ja":"[Molecular basis of ryanodine receptor-mediated Ca2+ release]"},"authors":{"en":[{"name":"Ikeda Atsushi"},{"name":"Yamazaki Tetsuo"},{"name":"Takeshima Hiroshi"}],"ja":[{"name":"Ikeda Atsushi"},{"name":"山﨑 哲男"},{"name":"Takeshima Hiroshi"}]},"publication_date":"2007-12","publication_name":{"en":"Tanpakushitsu Kakusan Koso","ja":"蛋白質 核酸 酵素"},"volume":"Vol.52","number":"No.15","starting_page":"1965","ending_page":"1972","languages":["jpn"],"identifiers":{"issn":["0039-9450"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"R000010784","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1521136280863139072/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378576","label":"url"}],"paper_title":{"en":"B細胞の分化・機能発現とBCAP","ja":"B細胞の分化・機能発現とBCAP"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2005-04","publication_name":{"en":"Clinical Immunology","ja":"臨床免疫"},"volume":"Vol.43","number":"No.4","starting_page":"483","ending_page":"486","languages":["jpn"],"identifiers":{"issn":["0386-9695"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"R000010784","type":"misc","id":"30377089"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40006740714/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=234635","label":"url"}],"paper_title":{"en":"B細胞の分化・機能発現とBCAP","ja":"B細胞の分化・機能発現とBCAP"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2005-04","publication_name":{"en":"Clinical Immunology","ja":"臨床免疫"},"volume":"Vol.43","number":"No.4","starting_page":"483","ending_page":"486","languages":["jpn"],"identifiers":{"issn":["0386-9695"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:9, {"insert":{"user_id":"R000010784","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1520854805196959488/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378579","label":"url"}],"paper_title":{"en":"B細胞の最終分化を決定するBCAPの核内転写因子c-Rel制御 (免疫細胞のシグナル伝達)","ja":"B細胞の最終分化を決定するBCAPの核内転写因子c-Rel制御 (免疫細胞のシグナル伝達)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2005","publication_name":{"en":"免疫 2006","ja":"免疫 2006"},"volume":"Vol.2005","starting_page":"165","ending_page":"170","languages":["jpn"],"identifiers":{"issn":["0918-6557"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:10, {"insert":{"user_id":"R000010784","type":"misc","id":"30377090"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40006532147/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=234634","label":"url"}],"paper_title":{"en":"B細胞の最終分化を決定するBCAPの核内転写因子c-Rel制御 (免疫細胞のシグナル伝達)","ja":"B細胞の最終分化を決定するBCAPの核内転写因子c-Rel制御 (免疫細胞のシグナル伝達)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2005","publication_name":{"en":"免疫","ja":"免疫"},"volume":"Vol.2005","starting_page":"165","ending_page":"170","languages":["jpn"],"identifiers":{"issn":["0918-6557"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:11, {"insert":{"user_id":"R000010784","type":"misc","id":"30377091"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1520573330734682624/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378582","label":"url"}],"paper_title":{"en":"成熟B細胞の維持におけるB cell adaptor for PI3 kinase(BCAP)の役割","ja":"成熟B細胞の維持におけるB cell adaptor for PI3 kinase(BCAP)の役割"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2004-05","publication_name":{"en":"Clinical Immunology","ja":"臨床免疫"},"volume":"Vol.41","number":"No.5","starting_page":"574","ending_page":"577","languages":["jpn"],"identifiers":{"issn":["0386-9695"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:12, {"insert":{"user_id":"R000010784","type":"misc"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40006253664/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=234633","label":"url"}],"paper_title":{"en":"成熟B細胞の維持におけるB cell adaptor for PI3 kinase(BCAP)の役割","ja":"成熟B細胞の維持におけるB cell adaptor for PI3 kinase(BCAP)の役割"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2004-05","publication_name":{"en":"Clinical Immunology","ja":"臨床免疫"},"volume":"Vol.41","number":"No.5","starting_page":"574","ending_page":"577","languages":["jpn"],"identifiers":{"issn":["0386-9695"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:13, {"insert":{"user_id":"R000010784","type":"misc","id":"33312370"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1521417755819914624/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378570","label":"url"}],"paper_title":{"en":"B細胞シグナルにおけるアダプター分子の機能発現機構 (B細胞シグナル伝達)","ja":"B細胞シグナルにおけるアダプター分子の機能発現機構 (B細胞シグナル伝達)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"黒崎 知博"}],"ja":[{"name":"山﨑 哲男"},{"name":"黒崎 知博"}]},"publication_date":"2003-10-18","publication_name":{"en":"Journal of Clinical and Experimental Medicine","ja":"医学のあゆみ"},"volume":"Vol.207","number":"No.3","starting_page":"174","ending_page":"178","identifiers":{"issn":["0039-2359"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:14, {"insert":{"user_id":"R000010784","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1521417755421346432/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378572","label":"url"}],"paper_title":{"en":"解説 B細胞の分化・機能発現とBCAP","ja":"解説 B細胞の分化・機能発現とBCAP"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"publication_date":"2003-02","publication_name":{"en":"Clinical Immunology","ja":"臨床免疫"},"volume":"Vol.39","number":"No.2","starting_page":"230","ending_page":"235","languages":["jpn"],"identifiers":{"issn":["0386-9695"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:15, {"insert":{"user_id":"R000010784","type":"misc","id":"33312371"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1523669554538206592/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378575","label":"url"}],"paper_title":{"en":"新規アダプター分子BCAPによる免疫制御機構 (免疫研究の最前線--高次複雑系免疫システムの包括的理解をめざして) -- (リンパ球活性化・細胞死のシグナル制御)","ja":"新規アダプター分子BCAPによる免疫制御機構 (免疫研究の最前線--高次複雑系免疫システムの包括的理解をめざして) -- (リンパ球活性化・細胞死のシグナル制御)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"黒崎 知博"}],"ja":[{"name":"山﨑 哲男"},{"name":"黒崎 知博"}]},"publication_date":"2002-12","publication_name":{"en":"Tanpakushitsu Kakusan Koso","ja":"蛋白質 核酸 酵素"},"volume":"Vol.47","number":"No.16","starting_page":"2242","ending_page":"2247","languages":["jpn"],"identifiers":{"issn":["0039-9450"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:16, {"insert":{"user_id":"R000010784","type":"misc","id":"30377092"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/12518443","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215085","label":"url"}],"paper_title":{"en":"[Immunoregulatory role for BCAP in B cell development and function]","ja":"[Immunoregulatory role for BCAP in B cell development and function]"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"Kurosaki Tomohiro"}],"ja":[{"name":"山﨑 哲男"},{"name":"Kurosaki Tomohiro"}]},"publication_date":"2002-12","publication_name":{"en":"Tanpakushitsu Kakusan Koso","ja":"蛋白質 核酸 酵素"},"volume":"Vol.47","number":"No.16 Suppl","starting_page":"2242","ending_page":"2247","languages":["jpn"],"identifiers":{"issn":["0039-9450"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:17, {"insert":{"user_id":"R000010784","type":"misc","id":"30377093"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215082","label":"url"}],"paper_title":{"en":"Interview about BCAP","ja":"Interview about BCAP"},"authors":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"description":{"en":"BCAP was recently cloned as a binding molecule to phosphoinositide 3-kinase (PI3K). To investigate the role of BCAP, mutant mice deficient in BCAP were generated. While BCAP-deficient mice are viable, they have decreased numbers of mature B cells and B1 B cell deficiency. The mice produce lower titers of serum immunoglobulin (Ig)M and IgG3, and mount attenuated responses to T cell--independent type II antigen. Upon B cell receptor cross-linking, BCAP-deficient B cells exhibit reduced Ca(2+) mobilization and poor proliferative responses. These findings demonstrate that BCAP plays a pivotal immunoregulatory role in B cell development and humoral immune responses.","ja":"BCAP was recently cloned as a binding molecule to phosphoinositide 3-kinase (PI3K). To investigate the role of BCAP, mutant mice deficient in BCAP were generated. While BCAP-deficient mice are viable, they have decreased numbers of mature B cells and B1 B cell deficiency. The mice produce lower titers of serum immunoglobulin (Ig)M and IgG3, and mount attenuated responses to T cell--independent type II antigen. Upon B cell receptor cross-linking, BCAP-deficient B cells exhibit reduced Ca(2+) mobilization and poor proliferative responses. These findings demonstrate that BCAP plays a pivotal immunoregulatory role in B cell development and humoral immune responses."},"publication_date":"2002-03-04","publication_name":{"en":"Modern Aspects of Immunobiol.","ja":"Modern Aspects of Immunobiol."},"volume":"Vol.2","starting_page":"154","ending_page":"154","languages":["eng"],"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:18, {"insert":{"user_id":"R000010784","type":"misc","id":"33312372"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1523669555184799616/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378558","label":"url"}],"paper_title":{"en":"T細胞抗原受容体を介するシグナル伝達 (特集 免疫系における情報伝達とその異常)","ja":"T細胞抗原受容体を介するシグナル伝達 (特集 免疫系における情報伝達とその異常)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"斉藤 隆"}],"ja":[{"name":"山﨑 哲男"},{"name":"斉藤 隆"}]},"publication_date":"1997-04","publication_name":{"en":"The Medical Frontline","ja":"最新医学"},"volume":"Vol.52","number":"No.4","starting_page":"759","ending_page":"767","languages":["jpn"],"identifiers":{"issn":["0370-8241"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:19, {"insert":{"user_id":"R000010784","type":"misc","id":"33312373"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1521136280220425088/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378564","label":"url"}],"paper_title":{"en":"TCRシグナルによるT細胞選択の調節 (免疫生物学)","ja":"TCRシグナルによるT細胞選択の調節 (免疫生物学)"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"斉藤 隆"}],"ja":[{"name":"山﨑 哲男"},{"name":"斉藤 隆"}]},"publication_date":"1996-08","publication_name":{"en":"免疫(1996-97)","ja":"免疫(1996-97)"},"number":"No.1996","starting_page":"101","ending_page":"111","languages":["jpn"],"identifiers":{"issn":["0918-6557"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:20, {"insert":{"user_id":"R000010784","type":"misc","id":"33312374"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378621","label":"url"}],"paper_title":{"en":"T細胞抗原受容体スーパーファミリー","ja":"T細胞抗原受容体スーパーファミリー"},"authors":{"en":[{"name":"Yamazaki Tetsuo"},{"name":"斉藤 隆"}],"ja":[{"name":"山﨑 哲男"},{"name":"斉藤 隆"}]},"publication_date":"1995-10-15","publication_name":{"en":"Science of the Living Body","ja":"生体の科学"},"volume":"Vol.46","number":"No.5","starting_page":"556","ending_page":"560","languages":["jpn"],"identifiers":{"doi":["10.11477/mf.2425901000"],"issn":["0370-9531"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:21, {"insert":{"user_id":"R000010784","type":"misc","id":"41876157"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394932","label":"url"}],"paper_title":{"en":"令和4年度 徳島大学高等教育研究センターアドミッション部門 報告書","ja":"令和4年度 徳島大学高等教育研究センターアドミッション部門 報告書"},"authors":{"en":[{"name":"Ueno Yoshihiko"},{"name":"Seki Yosuke"},{"name":"Kinugawa Satoshi"},{"name":"Morioka Hisayoshi"},{"name":"Takahashi Akira"},{"name":"Mori Kenji"},{"name":"Ishimaru Naozumi"},{"name":"Ozaki Kazumi"},{"name":"Yamazaki Tetsuo"},{"name":"Takada Atsushi"},{"name":"Uto Yoshihiro"},{"name":"Saito Takahito"},{"name":"Kamioka Maiko"}],"ja":[{"name":"植野 美彦"},{"name":"関 陽介"},{"name":"衣川 仁"},{"name":"森岡 久尚"},{"name":"髙橋 章"},{"name":"森 健治"},{"name":"石丸 直澄"},{"name":"尾崎 和美"},{"name":"山﨑 哲男"},{"name":"高田 篤"},{"name":"宇都 義浩"},{"name":"齊藤 隆仁"},{"name":"上岡 麻衣子"}]},"publication_date":"2023-03","publication_name":{"en":"令和4年度 徳島大学高等教育研究センターアドミッション部門 報告書","ja":"令和4年度 徳島大学高等教育研究センターアドミッション部門 報告書"},"languages":["jpn"],"misc_type":"others"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/misc.jsonl, frbjho4BzHGxATo5Tztr) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/books_etc.jsonl) ==== line:1, {"insert":{"user_id":"R000010784","type":"books_etc","id":"42910104"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=398862","label":"url"}],"book_title":{"en":"骨代謝マーカーハンドブック","ja":"骨代謝マーカーハンドブック"},"authors":{"en":[{"name":"斎藤 充"},{"name":"高田 潤一"},{"name":"Takata Shinjiro"},{"name":"竹内 靖博"},{"name":"茶木 修"},{"name":"中村 幸男"},{"name":"荻野 浩"},{"name":"三浦 雅一"},{"name":"元木 由美"},{"name":"森脇 好乃美"},{"name":"森脇 笙"},{"name":"Yamazaki Tetsuo"},{"name":"吉村 典子"}],"ja":[{"name":"斎藤 充"},{"name":"高田 潤一"},{"name":"髙田 信二郎"},{"name":"竹内 靖博"},{"name":"茶木 修"},{"name":"中村 幸男"},{"name":"荻野 浩"},{"name":"三浦 雅一"},{"name":"元木 由美"},{"name":"森脇 好乃美"},{"name":"森脇 笙"},{"name":"山﨑 哲男"},{"name":"吉村 典子"}]},"publisher":{"en":"Medical Review Co.,Ltd","ja":"メディカルレビュー社"},"publication_date":"2022-10-07","languages":["jpn"]},"priority":"input_data"} line:2, {"insert":{"user_id":"R000010784","type":"books_etc","id":"30377121"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=234061","label":"url"}],"book_title":{"en":"医歯薬系学生のためのillustrated基礎生命科学","ja":"医歯薬系学生のためのillustrated基礎生命科学"},"authors":{"en":[{"name":"竹島 浩"},{"name":"Yamazaki Tetsuo"},{"name":"池田 篤史"},{"name":"輿水 崇鏡"}],"ja":[{"name":"竹島 浩"},{"name":"山﨑 哲男"},{"name":"池田 篤史"},{"name":"輿水 崇鏡"}]},"publisher":{"en":"京都廣川書店","ja":"京都廣川書店"},"publication_date":"2008","languages":["jpn"]},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/books_etc.jsonl, gbbjho4BzHGxATo5UDtO) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/awards.jsonl) ==== line:1, {"insert":{"user_id":"R000010784","type":"awards","id":"30377120"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=341896","label":"url"}],"award_name":{"en":"平成29年度特別研究員等審査会専門委員表彰","ja":"平成29年度特別研究員等審査会専門委員表彰"},"winners":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"award_title":{"en":"平成29年度特別研究員等審査会専門委員表彰","ja":"平成29年度特別研究員等審査会専門委員表彰"},"association":{"en":"独立行政法人日本学術振興会","ja":"独立行政法人日本学術振興会"},"award_date":"2018-08-06"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/awards.jsonl, h7bjho4BzHGxATo5UTtR) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/presentations.jsonl) ==== line:1, {"insert":{"user_id":"R000010784","type":"presentations","id":"45575842"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405055","label":"url"}],"presentation_title":{"en":"CTSD integrity in the endoplasmic reticulum is required for CLN6's anti-aggregate activity","ja":"CTSD integrity in the endoplasmic reticulum is required for CLN6's anti-aggregate activity"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"The 20th annual WORLDSymposium 2024","ja":"The 20th annual WORLDSymposium 2024"},"publication_date":"2024-02-05","invited":true,"languages":["eng"],"location":{"en":"San Diego","ja":"San Diego"},"is_international_presentation":true},"priority":"input_data"} line:2, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097339"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385726","label":"url"}],"presentation_title":{"en":"Novel insight into the compound heterozygosity-driven CLN6 disease pathomechanism","ja":"Novel insight into the compound heterozygosity-driven CLN6 disease pathomechanism"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"The 18th annual WORLDSymposium 2022","ja":"The 18th annual WORLDSymposium 2022"},"publication_date":"2022-02-07","languages":["eng"],"location":{"en":"California","ja":"California"},"is_international_presentation":true},"priority":"input_data"} line:3, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097340"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385724","label":"url"}],"presentation_title":{"en":"Contribution of functional interference between CLN6 mutants to the pathogenesis of the neuronal ceroid lipofuscinoses","ja":"Contribution of functional interference between CLN6 mutants to the pathogenesis of the neuronal ceroid lipofuscinoses"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"The 17th International Congress on Neuronal Ceroid Lipofuscinosis","ja":"The 17th International Congress on Neuronal Ceroid Lipofuscinosis"},"publication_date":"2021-10-06","languages":["eng"],"location":{"en":"St Louis","ja":"St Louis"},"is_international_presentation":true},"priority":"input_data"} line:4, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097341"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385723","label":"url"}],"presentation_title":{"en":"Implications of graded reductions in CLN6's anti-aggregate activity as a pathomechanism of the neuronal ceroid lipofuscinoses","ja":"Implications of graded reductions in CLN6's anti-aggregate activity as a pathomechanism of the neuronal ceroid lipofuscinoses"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"The 45th FEBS Congres","ja":"The 45th FEBS Congres"},"publication_date":"2021-07-03","languages":["eng"],"location":{"en":"Ljubljana","ja":"Ljubljana"},"is_international_presentation":true},"priority":"input_data"} line:5, {"insert":{"user_id":"R000010784","type":"presentations","id":"31858353"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374311","label":"url"}],"presentation_title":{"en":"Differential impairment of CLN6s anti-aggregate activity as a pathogenic mechanism of CLN6 disease","ja":"Differential impairment of CLN6s anti-aggregate activity as a pathogenic mechanism of CLN6 disease"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"17th annual WORLDSymposium 2021","ja":"17th annual WORLDSymposium 2021"},"publication_date":"2021-02-08","languages":["eng"],"location":{"en":"Minnesota","ja":"Minnesota"},"is_international_presentation":true},"priority":"input_data"} line:6, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377094"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=340219","label":"url"}],"presentation_title":{"en":"ER-driven anti-aggregate activity toward pathogenic alphaB-crystallin mutants","ja":"ER-driven anti-aggregate activity toward pathogenic alphaB-crystallin mutants"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"山﨑 哲男"}]},"event":{"en":"The 43rd FEBS Congress","ja":"The 43rd FEBS Congress"},"publication_date":"2018-07-09","languages":["eng"],"location":{"en":"Praha","ja":"Praha"},"is_international_presentation":true},"priority":"input_data"} line:7, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377095"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=323037","label":"url"}],"presentation_title":{"en":"ER Manipulation: A promising therapeutic intervention for protein aggregation diseases","ja":"ER Manipulation: A promising therapeutic intervention for protein aggregation diseases"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Nakatsuru Takamitsu"},{"name":"Saito Hiroki"},{"name":"Hiraki Yuri"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"中鶴 貴允"},{"name":"齊藤 宏貴"},{"name":"Hiraki Yuri"},{"name":"山﨑 哲男"}]},"event":{"en":"The 3rd International Symposium on Regenerative Rehabilitation in Kyoto","ja":"The 3rd International Symposium on Regenerative Rehabilitation in Kyoto"},"publication_date":"2017-02-11","invited":true,"languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:8, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377096"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=309282","label":"url"}],"presentation_title":{"en":"ER as a potential therapeutic target for protein aggregation disease","ja":"ER as a potential therapeutic target for protein aggregation disease"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"The Fifth Bizan Immunology Symposium at The University of Tokushima","ja":"The Fifth Bizan Immunology Symposium at The University of Tokushima"},"publication_date":"2016-03-04","languages":["eng"],"location":{"en":"Tokushima","ja":"Tokushima"},"is_international_presentation":true},"priority":"input_data"} line:9, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377097"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=289909","label":"url"}],"presentation_title":{"en":"Manipulation of the ER: a novel strategy against protein desposition disease.","ja":"Manipulation of the ER: a novel strategy against protein desposition disease."},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"The Fourth Bizan Immunology Symposium at The University of Tokushima","ja":"The Fourth Bizan Immunology Symposium at The University of Tokushima"},"publication_date":"2015-01-30","languages":["eng"],"location":{"en":"Tokushima","ja":"Tokushima"},"is_international_presentation":true},"priority":"input_data"} line:10, {"insert":{"user_id":"R000010784","type":"presentations","id":"42454133"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397803","label":"url"}],"presentation_title":{"en":"Cathepsin Dは小胞体内腔でCLN6の凝集抑制能を支える","ja":"Cathepsin Dは小胞体内腔でCLN6の凝集抑制能を支える"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第21回四国免疫フォーラム","ja":"第21回四国免疫フォーラム"},"publication_date":"2023-06-03","languages":["jpn"],"location":{"en":"徳島市","ja":"徳島市"},"is_international_presentation":false},"priority":"input_data"} line:11, {"insert":{"user_id":"R000010784","type":"presentations","id":"42125575"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395544","label":"url"}],"presentation_title":{"en":"CLN10 A58V mutant interferes with the ER-driven anti-aggregate activity","ja":"CLN10 A58V変異体は小胞体膜微小環境に備わる凝集抑止機能を阻害する"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Katayama Syouichi"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"片山 将一"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第143年会(北海道)","ja":"日本薬学会第143年会(北海道)"},"publication_date":"2023-03-25","languages":["jpn"],"location":{"en":"北海道","ja":"北海道"},"is_international_presentation":false},"priority":"input_data"} line:12, {"insert":{"user_id":"R000010784","type":"presentations","id":"42125576"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395543","label":"url"}],"presentation_title":{"en":"CLN6s C-terminal mutants evaluation of the anti-aggregate activity and protein stability as a cause of CLN6 disease","ja":"CLN6のC末端領域変異における凝集抑止機能とタンパク質安定性に基づいたCLN6病の発症要因検討"},"presenters":{"en":[{"name":"Watanabe Kana"},{"name":"Shiro Yuki"},{"name":"Katayama Syouichi"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"渡邊 佳奈"},{"name":"城 裕己"},{"name":"片山 将一"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第143年会(北海道)","ja":"日本薬学会第143年会(北海道)"},"publication_date":"2023-03-25","languages":["jpn"],"location":{"en":"北海道","ja":"北海道"},"is_international_presentation":false},"priority":"input_data"} line:13, {"insert":{"user_id":"R000010784","type":"presentations","id":"42125577"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395542","label":"url"}],"presentation_title":{"en":"Role of cyclin-dependent kinase-like 5 during neuronal differentiation in vitro","ja":"Cyclin-dependent kinase-like 5のin vitro神経細胞分化における役割"},"presenters":{"en":[{"name":"Katayama Syouichi"},{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"片山 将一"},{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第143年会(北海道)","ja":"日本薬学会第143年会(北海道)"},"publication_date":"2023-03-25","languages":["jpn"],"location":{"en":"北海道","ja":"北海道"},"is_international_presentation":false},"priority":"input_data"} line:14, {"insert":{"user_id":"R000010784","type":"presentations","id":"42910105"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=398866","label":"url"}],"presentation_title":{"en":"CLN10変異体のもつ凝集抑止機能と疾患の関連性","ja":"CLN10変異体のもつ凝集抑止機能と疾患の関連性"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"超異分野学会 大阪大会2022","ja":"超異分野学会 大阪大会2022"},"publication_date":"2022-08-27","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:15, {"insert":{"user_id":"R000010784","type":"presentations","id":"37152134"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385844","label":"url"}],"presentation_title":{"en":"Cathepsin Dによる小胞体膜微小環境の制御機構解明","ja":"Cathepsin Dによる小胞体膜微小環境の制御機構解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第20回四国免疫フォーラム","ja":"第20回四国免疫フォーラム"},"publication_date":"2022-06-11","languages":["jpn"],"location":{"en":"オンライン開催","ja":"オンライン開催"},"is_international_presentation":false},"priority":"input_data"} line:16, {"insert":{"user_id":"R000010784","type":"presentations","id":"39716531"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=391109","label":"url"}],"presentation_title":{"en":"Establishment of a method for detecting the activity of cyclin-dependent kinase-like 5 in cellulo","ja":"Cyclin-dependent kinase-like 5の酵素活性をin celluloにおいて検出する手法の開発"},"presenters":{"en":[{"name":"Katayama Syouichi"},{"name":"城 祐己"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"片山 将一"},{"name":"城 祐己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第142年会(愛知)","ja":"日本薬学会第142年会(愛知)"},"publication_date":"2022-03-25","languages":["jpn"],"location":{"en":"愛知","ja":"愛知"},"is_international_presentation":false},"priority":"input_data"} line:17, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097344"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385720","label":"url"}],"presentation_title":{"en":"CLN6-CLN10 complex regulates ER-driven anti-aggregate activity","ja":"小胞体膜微小環境におけるCLN6-CLN10複合体は凝集抑止機能を制御する"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第142年会","ja":"日本薬学会第142年会"},"publication_date":"2022-03-25","languages":["jpn"],"location":{"en":"愛知","ja":"愛知"},"is_international_presentation":false},"priority":"input_data"} line:18, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097345"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385719","label":"url"}],"presentation_title":{"en":"vPreventing neurodegenerative disease through ER-driven anti-aggregate activity","ja":"小胞体駆動の凝集抑止が神経変性疾患を防ぐ"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"超異分野学会 東京大会2022","ja":"超異分野学会 東京大会2022"},"publication_date":"2022-03-04","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:19, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097346"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385718","label":"url"}],"presentation_title":{"en":"小胞体膜近傍タンパク質複合体の障害による凝集体蓄積疾患の発症メカニズム","ja":"小胞体膜近傍タンパク質複合体の障害による凝集体蓄積疾患の発症メカニズム"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第112回蔵本免疫懇話会","ja":"第112回蔵本免疫懇話会"},"publication_date":"2022-01-26","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:20, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097347"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385717","label":"url"}],"presentation_title":{"en":"稀少疾患CLN6病の発病予測システムの開発に向けて","ja":"稀少疾患CLN6病の発病予測システムの開発に向けて"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"超異分野学会 香川フォーラム2021","ja":"超異分野学会 香川フォーラム2021"},"publication_date":"2021-12-04","languages":["jpn"],"location":{"en":"Kagawa","ja":"香川"},"is_international_presentation":false},"priority":"input_data"} line:21, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097348"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385716","label":"url"}],"presentation_title":{"en":"Establishment of a method for detecting the substrate phosphorylation activity of cyclin-dependent kinase-like 5 using an artificial substrate","ja":"人工基質を用いたcyclin-dependent kinase-like 5 の基質リン酸化活性を検出する手法の開発"},"presenters":{"en":[{"name":"Katayama Syouichi"},{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"片山 将一"},{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第44回日本分子生物学会","ja":"第44回日本分子生物学会"},"publication_date":"2021-12-01","languages":["jpn"],"location":{"en":"Kanagawa","ja":"神奈川"},"is_international_presentation":false},"priority":"input_data"} line:22, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097349"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385715","label":"url"}],"presentation_title":{"en":"Molecular mechanisms underlying the loss of anti-aggregate activity with mutations in CLN6's C-terminal region","ja":"CLN6のC末端領域変異体が凝集抑止機能を喪失するメカニズムの解析"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第44回日本分子生物学会","ja":"第44回日本分子生物学会"},"publication_date":"2021-12-01","languages":["jpn"],"location":{"en":"Kanagawa","ja":"神奈川"},"is_international_presentation":false},"priority":"input_data"} line:23, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097350"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385714","label":"url"}],"presentation_title":{"en":"小胞体を中心とするタンパク質恒常性を支える分子メカニズムの解明","ja":"小胞体を中心とするタンパク質恒常性を支える分子メカニズムの解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第4回 kenQ-Pitch Osaka","ja":"第4回 kenQ-Pitch Osaka"},"publication_date":"2021-11-28","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:24, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097351"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385713","label":"url"}],"presentation_title":{"en":"Phos-tag SDS-PAGEを利用したcyclin-dependent kinase-like 5の基質リン酸化検出法の開発","ja":"Phos-tag SDS-PAGEを利用したcyclin-dependent kinase-like 5の基質リン酸化検出法の開発"},"presenters":{"en":[{"name":"Katayama Syouichi"},{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"片山 将一"},{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第60回日本薬学会中国四国支部学術大会","ja":"第60回日本薬学会中国四国支部学術大会"},"publication_date":"2021-10-23","languages":["jpn"],"location":{"en":"愛媛","ja":"愛媛"},"is_international_presentation":false},"priority":"input_data"} line:25, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097352"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385712","label":"url"}],"presentation_title":{"en":"複合ヘテロ接合型CLN6病における凝集抑止活性を消失させる新たなメカニズムの解明","ja":"複合ヘテロ接合型CLN6病における凝集抑止活性を消失させる新たなメカニズムの解明"},"presenters":{"en":[{"name":"Watanabe Kana"},{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"渡邉 佳奈"},{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第60回日本薬学会中国四国支部学術大会","ja":"第60回日本薬学会中国四国支部学術大会"},"publication_date":"2021-10-23","languages":["jpn"],"location":{"en":"愛媛","ja":"愛媛"},"is_international_presentation":false},"priority":"input_data"} line:26, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097353"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385711","label":"url"}],"presentation_title":{"en":"Examination of clinical features about compound heterozygous CLN6 disease with the CLN6 P299L missense mutant","ja":"CLN6 P299L変異を有する複合ヘテロ接合型CLN6病の臨床症状を検討する"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本人類遺伝学会 第66回大会","ja":"日本人類遺伝学会 第66回大会"},"publication_date":"2021-10-13","languages":["jpn"],"location":{"en":"Kanagawa","ja":"神奈川"},"is_international_presentation":false},"priority":"input_data"} line:27, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097354"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385710","label":"url"}],"presentation_title":{"en":"CLN6 missense mutant (P299L) was selectively vulnerable to the frameshift mutant (S132fs)","ja":"CLN6のフレームシフト変異体(S132fs)はミスセンス変異体(P299L)の機能を喪失させる"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本遺伝学会 第93回大会","ja":"日本遺伝学会 第93回大会"},"publication_date":"2021-09-08","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:28, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097355"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385709","label":"url"}],"presentation_title":{"en":"凝集体難病予防に向けた小胞体膜タンパク質品質管理機構の解明","ja":"凝集体難病予防に向けた小胞体膜タンパク質品質管理機構の解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第20回次世代を担う若手ファーマ・バイオフォーラム2021","ja":"第20回次世代を担う若手ファーマ・バイオフォーラム2021"},"publication_date":"2021-08-28","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:29, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097356"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385708","label":"url"}],"presentation_title":{"en":"小胞体膜を取り巻く相互作用分子の可能性","ja":"小胞体膜を取り巻く相互作用分子の可能性"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第2回 kenQ-Pitch Osaka","ja":"第2回 kenQ-Pitch Osaka"},"publication_date":"2021-08-22","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:30, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097357"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385707","label":"url"}],"presentation_title":{"en":"凝集抑止活性を指標とした複合ヘテロ接合型CLN6病の発症メカニズム検討","ja":"凝集抑止活性を指標とした複合ヘテロ接合型CLN6病の発症メカニズム検討"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第61回日本先天異常学術集会","ja":"第61回日本先天異常学術集会"},"publication_date":"2021-08-07","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:31, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097358"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385706","label":"url"}],"presentation_title":{"en":"小胞体膜に備わる凝集抑止機能の制御メカニズム解明","ja":"小胞体膜に備わる凝集抑止機能の制御メカニズム解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第1回 kenQ-Pitch Osaka","ja":"第1回 kenQ-Pitch Osaka"},"publication_date":"2021-06-27","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:32, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097359"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385705","label":"url"}],"presentation_title":{"en":"複合ヘテロ接合型CLN6病における凝集抑止機能の制御メカニズム解明","ja":"複合ヘテロ接合型CLN6病における凝集抑止機能の制御メカニズム解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第19回四国免疫フォーラム","ja":"第19回四国免疫フォーラム"},"publication_date":"2021-06-26","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:33, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097360"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385704","label":"url"}],"presentation_title":{"en":"lucidation of the pathomechanism of CLN6 disease","ja":"稀少疾患CLN6病の発症メカニズム解明"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"超異分野学会 大阪大会2021","ja":"超異分野学会 大阪大会2021"},"publication_date":"2021-04-24","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:34, {"insert":{"user_id":"R000010784","type":"presentations","id":"31858354"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374313","label":"url"}],"presentation_title":{"en":"複合ヘテロ接合型CLN6病の原因として見出した抗凝集体活性の喪失","ja":"複合ヘテロ接合型CLN6病の原因として見出した抗凝集体活性の喪失"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第141年会","ja":"日本薬学会第141年会"},"publication_date":"2021-03-26","languages":["jpn"],"location":{"en":"広島大学","ja":"広島大学"},"is_international_presentation":false},"priority":"input_data"} line:35, {"insert":{"user_id":"R000010784","type":"presentations","id":"37097361"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385721","label":"url"}],"presentation_title":{"en":"Establishment of a method for detecting the activity of cyclin-dependent kinase-like 5 in cellulo","ja":"Cyclin-dependent kinase-like 5の酵素活性をin celluloにおいて検出する手法の開発"},"presenters":{"en":[{"name":"Katayama Syouichi"},{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"片山 将一"},{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"日本薬学会第142年会","ja":"日本薬学会第142年会"},"publication_date":"2021-03-25","languages":["jpn"],"location":{"en":"愛知","ja":"愛知"},"is_international_presentation":false},"priority":"input_data"} line:36, {"insert":{"user_id":"R000010784","type":"presentations","id":"31858355"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374312","label":"url"}],"presentation_title":{"en":"Employ the ER membrane toward preventing aggregate formation","ja":"小胞体膜を使って凝集を防ぐ"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第10回超異分野学会","ja":"第10回超異分野学会"},"publication_date":"2021-03-05","languages":["jpn"],"location":{"en":"東京 羽田コングレスエア","ja":"東京 羽田コングレスエア"},"is_international_presentation":false},"priority":"input_data"} line:37, {"insert":{"user_id":"R000010784","type":"presentations","id":"31858356"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374310","label":"url"}],"presentation_title":{"en":"CLN6変異による抗凝集体活性の喪失とCLN6病発症の関係","ja":"CLN6変異による抗凝集体活性の喪失とCLN6病発症の関係"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山﨑 哲男"}]},"event":{"en":"第59回日本薬学会中国四国支部学術大会","ja":"第59回日本薬学会中国四国支部学術大会"},"publication_date":"2020-12-07","languages":["jpn"],"location":{"en":"松江市","ja":"松江市"},"is_international_presentation":false},"priority":"input_data"} line:38, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377098"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=358910","label":"url"}],"presentation_title":{"en":"Defects in ER-driven anti-aggregate activity as a cause of CLN6 disease","ja":"小胞体膜微小環境に備わる抗凝集体活性の障害がCLN6病を引き起こす"},"presenters":{"en":[{"name":"Shiro Yuki"},{"name":"Yamashita Arisa"},{"name":"Hiraki Yuri"},{"name":"Yujiri Takatoshi"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"城 裕己"},{"name":"山下 ありさ"},{"name":"平木 友理"},{"name":"湯尻 貴俊"},{"name":"山﨑 哲男"}]},"event":{"en":"稀少疾患カンファランス","ja":"稀少疾患カンファランス"},"publication_date":"2019-08-30","invited":true,"languages":["jpn"],"promoter":{"en":"立命館大学 びわこ・くさつキャンパス","ja":"立命館大学 びわこ・くさつキャンパス"},"is_international_presentation":false},"priority":"input_data"} line:39, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377099"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=352678","label":"url"}],"presentation_title":{"en":"小胞体膜微小環境病としての神経セロイドリポフスチン症","ja":"小胞体膜微小環境病としての神経セロイドリポフスチン症"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"立命館大学 稀少疾患プロジェクト オープンセミナー","ja":"立命館大学 稀少疾患プロジェクト オープンセミナー"},"publication_date":"2019-06-26","invited":true,"languages":["jpn"],"location":{"en":"滋賀県草津市","ja":"滋賀県草津市"},"is_international_presentation":false},"priority":"input_data"} line:40, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377100"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=340217","label":"url"}],"presentation_title":{"en":"小胞体マニピュレーションの汎用性とその分子基盤","ja":"小胞体マニピュレーションの汎用性とその分子基盤"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Hiraki Yuri"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"平木 友理"},{"name":"山﨑 哲男"}]},"event":{"en":"第17回 四国免疫フォーラム","ja":"第17回 四国免疫フォーラム"},"publication_date":"2018-06-30","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:41, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377101"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325331","label":"url"}],"presentation_title":{"en":"タンパク質凝集体難病の克服に向けた小胞体操作法の開発","ja":"タンパク質凝集体難病の克服に向けた小胞体操作法の開発"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"立命館大学 稀少疾患プロジェクト オープンセミナー","ja":"立命館大学 稀少疾患プロジェクト オープンセミナー"},"publication_date":"2017-06-22","invited":true,"languages":["jpn"],"location":{"en":"滋賀県草津市","ja":"滋賀県草津市"},"is_international_presentation":false},"priority":"input_data"} line:42, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377102"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325330","label":"url"}],"presentation_title":{"en":"小胞体マニピュレーションがもたらす抗凝集体活性の分子基盤","ja":"小胞体マニピュレーションがもたらす抗凝集体活性の分子基盤"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Hiraki Yuri"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"平木 友理"},{"name":"山﨑 哲男"}]},"event":{"en":"第16回 四国免疫フォーラム","ja":"第16回 四国免疫フォーラム"},"publication_date":"2017-06-17","languages":["jpn"],"location":{"en":"香川県木田郡三木町池戸","ja":"香川県木田郡三木町池戸"},"is_international_presentation":false},"priority":"input_data"} line:43, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377103"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=323038","label":"url"}],"presentation_title":{"en":"凝集体難病の克服に向けた小胞体操縦法","ja":"凝集体難病の克服に向けた小胞体操縦法"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"福井大学医学系研究科 第567回学内セミナー (大学院セミナー)","ja":"福井大学医学系研究科 第567回学内セミナー (大学院セミナー)"},"publication_date":"2017-01-27","invited":true,"languages":["jpn"],"location":{"en":"Fukui","ja":"福井"},"is_international_presentation":false},"priority":"input_data"} line:44, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377104"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314119","label":"url"}],"presentation_title":{"en":"タンパク質凝集体難病の克服に向けた小胞体操作の分子基盤","ja":"タンパク質凝集体難病の克服に向けた小胞体操作の分子基盤"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"山﨑 哲男"}]},"event":{"en":"第15回 四国免疫フォーラム","ja":"第15回 四国免疫フォーラム"},"publication_date":"2016-06-25","languages":["jpn"],"location":{"en":"高知県南国市","ja":"高知県南国市"},"is_international_presentation":false},"priority":"input_data"} line:45, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377105"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=305235","label":"url"}],"presentation_title":{"en":"小胞体を標的とした凝集体難病治療法開発","ja":"小胞体を標的とした凝集体難病治療法開発"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"山﨑 哲男"}]},"event":{"en":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2015-10","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:46, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377106"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=295305","label":"url"}],"presentation_title":{"en":"ER-based therapeutic strategies toward protein deposition diseases","ja":"小胞体マニピュレーションに基づく凝集難病治療法の創出"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"山﨑 哲男"}]},"event":{"en":"第14回 四国免疫フォーラム","ja":"第14回 四国免疫フォーラム"},"publication_date":"2015-06-20","languages":["jpn"],"location":{"en":"愛媛県東温市","ja":"愛媛県東温市"},"is_international_presentation":false},"priority":"input_data"} line:47, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377107"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287576","label":"url"}],"presentation_title":{"en":"A role of the ER protein calumin in the protein quality control system","ja":"タンパク質品質管理機構における calumin の役割"},"presenters":{"en":[{"name":"Yamamto Shin-ichiro"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山本 伸一郎"},{"name":"山﨑 哲男"}]},"event":{"en":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2014-11-08","languages":["jpn"],"location":{"en":"広島市","ja":"広島市"},"is_international_presentation":false},"priority":"input_data"} line:48, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377108"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279565","label":"url"}],"presentation_title":{"en":"Study of the method for development of case-problem solving abilities through advanced practice and the results that have been achieved","ja":"アドバンスト演習を通した問題解決能力向上のための症例解析手法の検討-プロダクトからの分析"},"presenters":{"en":[{"name":"中西 智子"},{"name":"Ishizawa Keisuke"},{"name":"Abe Shinji"},{"name":"Nakase Mari"},{"name":"Shibata Hirofumi"},{"name":"Sato Chiemi"},{"name":"Arakaki Naokatu"},{"name":"Sato Youichi"},{"name":"Yamazaki Naoshi"},{"name":"Kasahara Jiro"},{"name":"Azuma Mami"},{"name":"Yamazaki Tetsuo"},{"name":"Yamauchi Aiko"},{"name":"Takiguchi Yoshiharu"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"中西 智子"},{"name":"石澤 啓介"},{"name":"阿部 真治"},{"name":"中瀬 真理"},{"name":"柴田 洋文"},{"name":"佐藤 智恵美"},{"name":"新垣 尚捷"},{"name":"佐藤 陽一"},{"name":"山﨑 尚志"},{"name":"笠原 二郎"},{"name":"東 満美"},{"name":"山﨑 哲男"},{"name":"山内 あい子"},{"name":"滝口 祥令"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬学会第134年会","ja":"日本薬学会第134年会"},"publication_date":"2014-03-29","languages":["jpn"],"location":{"en":"熊本市","ja":"熊本市"},"is_international_presentation":false},"priority":"input_data"} line:49, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377109"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=280596","label":"url"}],"presentation_title":{"en":"Study of the method for development of case-problem solving abilities through advanced practice and the results that have been achieved","ja":"アドバンスト演習を通した問題解決能力向上のための症例解析手法の検討"},"presenters":{"en":[{"name":"中西 智子"},{"name":"Ishizawa Keisuke"},{"name":"Abe Shinji"},{"name":"Nakase Mari"},{"name":"Shibata Hirofumi"},{"name":"Sato Chiemi"},{"name":"Arakaki Naokatu"},{"name":"Sato Youichi"},{"name":"Yamazaki Naoshi"},{"name":"Kasahara Jiro"},{"name":"Azuma Mami"},{"name":"Yamazaki Tetsuo"},{"name":"Yamauchi Aiko"},{"name":"Takiguchi Yoshiharu"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"中西 智子"},{"name":"石澤 啓介"},{"name":"阿部 真治"},{"name":"中瀬 真理"},{"name":"柴田 洋文"},{"name":"佐藤 智恵美"},{"name":"新垣 尚捷"},{"name":"佐藤 陽一"},{"name":"山﨑 尚志"},{"name":"笠原 二郎"},{"name":"東 満美"},{"name":"山﨑 哲男"},{"name":"山内 あい子"},{"name":"滝口 祥令"},{"name":"土屋 浩一郎"}]},"event":{"en":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2013-10-26","languages":["jpn"],"location":{"en":"Matsuyama","ja":"松山"},"is_international_presentation":false},"priority":"input_data"} line:50, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377110"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=261615","label":"url"}],"presentation_title":{"en":"ケミカルツールを用いたsiRNA-タンパク質間の相互作用様式解明","ja":"ケミカルツールを用いたsiRNA-タンパク質間の相互作用様式解明"},"presenters":{"en":[{"name":"Kira Hirotaka"},{"name":"Yamashita Arisa"},{"name":"Yamanaka Naoya"},{"name":"Furukawa Kazuhiro"},{"name":"Yamazaki Tetsuo"},{"name":"Ishida Tatsuhiro"},{"name":"Kiwada Hiroshi"},{"name":"Minakawa Noriaki"}],"ja":[{"name":"吉良 太孝"},{"name":"山下 ありさ"},{"name":"山中 直哉"},{"name":"古川 和寛"},{"name":"山﨑 哲男"},{"name":"石田 竜弘"},{"name":"際田 弘志"},{"name":"南川 典昭"}]},"event":{"en":"第133年会日本薬学会","ja":"第133年会日本薬学会"},"publication_date":"2013-03-28","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:51, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377111"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=261690","label":"url"}],"presentation_title":{"en":"小胞体タンパク質EPIGは紫外線照射による細胞死を抑制する","ja":"小胞体タンパク質EPIGは紫外線照射による細胞死を抑制する"},"presenters":{"en":[{"name":"Yamashita Arisa"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山下 ありさ"},{"name":"山﨑 哲男"}]},"event":{"en":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2012-11-11","languages":["jpn"],"location":{"en":"Matsue","ja":"松江"},"is_international_presentation":false},"priority":"input_data"} line:52, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377112"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=261613","label":"url"}],"presentation_title":{"en":"ミトコンドリア由来のROSシグナルは骨芽細胞の分化を誘導する","ja":"ミトコンドリア由来のROSシグナルは骨芽細胞の分化を誘導する"},"presenters":{"en":[{"name":"Komada Munekazu"},{"name":"Arakaki Naokatu"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"駒田 致和"},{"name":"新垣 尚捷"},{"name":"山﨑 哲男"}]},"event":{"en":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2012-11-10","languages":["jpn"],"location":{"en":"松江","ja":"松江"},"is_international_presentation":false},"priority":"input_data"} line:53, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377113"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242624","label":"url"}],"presentation_title":{"en":"小胞体タンパク質EPIGの紫外線応答における役割","ja":"小胞体タンパク質EPIGの紫外線応答における役割"},"presenters":{"en":[{"name":"Hondoh Eri"},{"name":"Masui Shunsuke"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"本藤 栄里"},{"name":"桝井 俊輔"},{"name":"山﨑 哲男"}]},"event":{"en":"第50回 日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第50回 日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2011-11-13","languages":["jpn"],"location":{"en":"高松市","ja":"高松市"},"is_international_presentation":false},"priority":"input_data"} line:54, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377114"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242623","label":"url"}],"presentation_title":{"en":"DNA損傷応答を規定する小胞体のシグナル特性","ja":"DNA損傷応答を規定する小胞体のシグナル特性"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"平成23年度第3回革新的特色研究シンポジウム「分子イメージング手法を導入した免疫疾患克服の革新的研究」","ja":"平成23年度第3回革新的特色研究シンポジウム「分子イメージング手法を導入した免疫疾患克服の革新的研究」"},"publication_date":"2011-11-09","languages":["jpn"],"location":{"en":"徳島市","ja":"徳島市"},"is_international_presentation":false},"priority":"input_data"} line:55, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377115"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=236017","label":"url"}],"presentation_title":{"en":"遺伝情報システムと免疫システムのクロストーク","ja":"遺伝情報システムと免疫システムのクロストーク"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"平成22年度第3回革新的特色研究シンポジウム「分子イメージング手法を導入した免疫疾患克服の革新的研究」","ja":"平成22年度第3回革新的特色研究シンポジウム「分子イメージング手法を導入した免疫疾患克服の革新的研究」"},"publication_date":"2010-11-17","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:56, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377116"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=236355","label":"url"}],"presentation_title":{"en":"徳島大学における薬学部・薬剤部連携による病院実務実習の実践","ja":"徳島大学における薬学部・薬剤部連携による病院実務実習の実践"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"中西 智子"},{"name":"Shibata Hirofumi"},{"name":"Abe Shinji"},{"name":"Sugimura Mayumi"},{"name":"Okumura Chieko"},{"name":"Yoshimura Yoshiyuki"},{"name":"Sato Youichi"},{"name":"Arakaki Naokatu"},{"name":"Kawazoe Kazuyoshi"},{"name":"Azuma Mami"},{"name":"Tsuchiya Koichiro"},{"name":"Yamauchi Aiko"},{"name":"Yamazaki Tetsuo"},{"name":"Minakuchi Kazuo"}],"ja":[{"name":"石澤 啓介"},{"name":"中西 智子"},{"name":"柴田 洋文"},{"name":"阿部 真治"},{"name":"杉村 真由美"},{"name":"奥村 千恵子"},{"name":"吉村 好之"},{"name":"佐藤 陽一"},{"name":"新垣 尚捷"},{"name":"川添 和義"},{"name":"東 満美"},{"name":"土屋 浩一郎"},{"name":"山内 あい子"},{"name":"山﨑 哲男"},{"name":"水口 和生"}]},"event":{"en":"第20回日本医療薬学会年会","ja":"第20回日本医療薬学会年会"},"publication_date":"2010-11-13","languages":["jpn"],"location":{"en":"Chiba","ja":"千葉"},"is_international_presentation":false},"priority":"input_data"} line:57, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377117"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=235778","label":"url"}],"presentation_title":{"en":"病院施設のATP拭き取り検査と細菌汚染状況調査","ja":"病院施設のATP拭き取り検査と細菌汚染状況調査"},"presenters":{"en":[{"name":"渡邉 美穂"},{"name":"Shibata Hirofumi"},{"name":"上松 卓"},{"name":"伏谷 秀治"},{"name":"Abe Shinji"},{"name":"Kawazoe Kazuyoshi"},{"name":"Yamazaki Tetsuo"},{"name":"Minakuchi Kazuo"}],"ja":[{"name":"渡邉 美穂"},{"name":"柴田 洋文"},{"name":"上松 卓"},{"name":"伏谷 秀治"},{"name":"阿部 真治"},{"name":"川添 和義"},{"name":"山﨑 哲男"},{"name":"水口 和生"}]},"event":{"en":"第49回 日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第49回 日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2010-11-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:58, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377118"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=236005","label":"url"}],"presentation_title":{"en":"小胞体のシグナル特性から免疫へ","ja":"小胞体のシグナル特性から免疫へ"},"presenters":{"en":[{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"山﨑 哲男"}]},"event":{"en":"免疫シグナルシンポジウム","ja":"免疫シグナルシンポジウム"},"publication_date":"2010-10-30","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:59, {"insert":{"user_id":"R000010784","type":"presentations","id":"30377119"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=236004","label":"url"}],"presentation_title":{"en":"小胞体タンパク質MG23によるDNA損傷誘導性細胞死の促進","ja":"小胞体タンパク質MG23によるDNA損傷誘導性細胞死の促進"},"presenters":{"en":[{"name":"Masui Shunsuke"},{"name":"Yamazaki Tetsuo"}],"ja":[{"name":"桝井 俊輔"},{"name":"山﨑 哲男"}]},"event":{"en":"第117回 日本薬理学会近畿部会","ja":"第117回 日本薬理学会近畿部会"},"publication_date":"2010-07-08","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:60, {"insert":{"user_id":"R000010784","type":"presentations","id":"33312375"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1390845713041900800/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378584","label":"url"}],"presentation_title":{"en":"P1-571 徳島大学における薬学部・薬剤部連携による病院実務実習の実践(一般演題 ポスター発表,薬学教育(実務実習),臨床から学び臨床へと還元する医療薬学)","ja":"P1-571 徳島大学における薬学部・薬剤部連携による病院実務実習の実践(一般演題 ポスター発表,薬学教育(実務実習),臨床から学び臨床へと還元する医療薬学)"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Azuma Mami"},{"name":"Tsuchiya Koichiro"},{"name":"Yamauchi Aiko"},{"name":"Yamazaki Tetsuo"},{"name":"Minakuchi Kazuo"},{"name":"中西 智子"},{"name":"Shibata Hirofumi"},{"name":"Abe Shinji"},{"name":"Sugimura Mayumi"},{"name":"Okumura Chieko"},{"name":"Yoshimura Yoshiyuki"},{"name":"Sato Youichi"},{"name":"Arakaki Naokatu"}],"ja":[{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"東 満美"},{"name":"土屋 浩一郎"},{"name":"山内 あい子"},{"name":"山﨑 哲男"},{"name":"水口 和生"},{"name":"中西 智子"},{"name":"柴田 洋文"},{"name":"阿部 真治"},{"name":"杉村 真由美"},{"name":"奥村 千恵子"},{"name":"吉村 好之"},{"name":"佐藤 陽一"},{"name":"新垣 尚捷"}]},"event":{"en":"The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences","ja":"日本医療薬学会年会講演要旨集"},"publication_date":"2010","languages":["jpn"],"promoter":{"en":"Japanese Society of Pharmaceutical Health Care and Sciences","ja":"一般社団法人 日本医療薬学会"},"is_international_presentation":false},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/201602/researchmap/presentations.jsonl, jrbjho4BzHGxATo5Ujt6) ==== ====== BulkResult(R000010784, dLbjho4BzHGxATo5TjtC) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:38Z","end_datetime":"2024-03-28T21:25:38Z","estimated_end_datetime":"2024-03-28T21:25:39Z","total_items":33} --- success {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:38Z","end_datetime":"2024-03-28T21:25:38Z","estimated_end_datetime":"2024-03-28T21:25:39Z","total_items":33} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"33896143","link":"https://api.researchmap.jp/tyamazaki/published_papers/33896143","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33896143]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33335783","link":"https://api.researchmap.jp/tyamazaki/published_papers/33335783","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33335783]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377056","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377056","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377056]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377057","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377057","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377057]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377058","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377058","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377058]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377059","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377059","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377059]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377060","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377060","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377060]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377061","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377061","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377061]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377062","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377062","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377062]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377063","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377063","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377063]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377064","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377064","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377064]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377065","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377065","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377065]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377066","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377066","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377066]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377067","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377067","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377067]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377068","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377068","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377068]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377069","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377069","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377069]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377070","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377070","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377070]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377071","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377071","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377071]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377072","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377072","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377072]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377073","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377073","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377073]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377074","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377074","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377074]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377075","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377075","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377075]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377076","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377076","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377076]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377077","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377077","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377077]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377078","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377078","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377078]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377079","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377079","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377079]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377080","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377080","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377080]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377081","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377081","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377081]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377082","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377082","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377082]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377083","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377083","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377083]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30377084","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377084","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377084]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30377085","link":"https://api.researchmap.jp/tyamazaki/published_papers/30377085","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377085]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45575840","link":"https://api.researchmap.jp/tyamazaki/published_papers/45575840","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45575840]。"}]} ====== BulkResult(R000010784, dLbjho4BzHGxATo5TjtC) : End ====== ====== BulkResult(R000010784, frbjho4BzHGxATo5Tztr) : Begin ====== --- error {"code":400,"status":"error","start_datetime":"2024-03-28T21:25:43Z","end_datetime":"2024-03-28T21:25:43Z","estimated_end_datetime":"2024-03-28T21:25:44Z","total_items":21,"process_items":21,"error_items":1} {"no":1,"line":14,"code":409,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"30377089","link":"https://api.researchmap.jp/tyamazaki/misc/30377089","errors":[{"code":409,"error":"conflict","error_description":"データが衝突(Conflict)し、更新できませんでした[30377089]。"}]} --- success {"code":400,"status":"error","start_datetime":"2024-03-28T21:25:43Z","end_datetime":"2024-03-28T21:25:43Z","estimated_end_datetime":"2024-03-28T21:25:44Z","total_items":21,"process_items":21,"error_items":1} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"36260686","link":"https://api.researchmap.jp/tyamazaki/misc/36260686","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =36260686]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312369","link":"https://api.researchmap.jp/tyamazaki/misc/33312369","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312369]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"force","type":"misc","id":"30377086","link":"https://api.researchmap.jp/tyamazaki/misc/30377086","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377086]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30377087","link":"https://api.researchmap.jp/tyamazaki/misc/30377087","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377087]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"misc","id":"30377088","link":"https://api.researchmap.jp/tyamazaki/misc/30377088","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377088]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"30377088","link":"https://api.researchmap.jp/tyamazaki/misc/30377088","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=30377088]。"}]} {"no":1,"line":7,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"30377089","link":"https://api.researchmap.jp/tyamazaki/misc/30377089"} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30377089","link":"https://api.researchmap.jp/tyamazaki/misc/30377089","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377089]。"}]} {"no":1,"line":9,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"30377090","link":"https://api.researchmap.jp/tyamazaki/misc/30377090"} {"no":1,"line":10,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30377090","link":"https://api.researchmap.jp/tyamazaki/misc/30377090","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377090]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"force","type":"misc","id":"30377091","link":"https://api.researchmap.jp/tyamazaki/misc/30377091","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30377091]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"30377091","link":"https://api.researchmap.jp/tyamazaki/misc/30377091","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=30377091]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312370","link":"https://api.researchmap.jp/tyamazaki/misc/33312370","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312370]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312371","link":"https://api.researchmap.jp/tyamazaki/misc/33312371","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312371]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30377092","link":"https://api.researchmap.jp/tyamazaki/misc/30377092","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377092]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30377093","link":"https://api.researchmap.jp/tyamazaki/misc/30377093","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377093]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312372","link":"https://api.researchmap.jp/tyamazaki/misc/33312372","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312372]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312373","link":"https://api.researchmap.jp/tyamazaki/misc/33312373","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312373]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33312374","link":"https://api.researchmap.jp/tyamazaki/misc/33312374","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312374]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"41876157","link":"https://api.researchmap.jp/tyamazaki/misc/41876157","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41876157]。"}]} ====== BulkResult(R000010784, frbjho4BzHGxATo5Tztr) : End ====== ====== BulkResult(R000010784, gbbjho4BzHGxATo5UDtO) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:48Z","end_datetime":"2024-03-28T21:25:48Z","estimated_end_datetime":"2024-03-28T21:25:49Z","total_items":2} --- success {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:48Z","end_datetime":"2024-03-28T21:25:48Z","estimated_end_datetime":"2024-03-28T21:25:49Z","total_items":2} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"42910104","link":"https://api.researchmap.jp/tyamazaki/books_etc/42910104","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42910104]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30377121","link":"https://api.researchmap.jp/tyamazaki/books_etc/30377121","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377121]。"}]} ====== BulkResult(R000010784, gbbjho4BzHGxATo5UDtO) : End ====== ====== BulkResult(R000010784, h7bjho4BzHGxATo5UTtR) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:53Z","end_datetime":"2024-03-28T21:25:53Z","estimated_end_datetime":"2024-03-28T21:25:54Z","total_items":1} --- success {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:53Z","end_datetime":"2024-03-28T21:25:53Z","estimated_end_datetime":"2024-03-28T21:25:54Z","total_items":1} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"awards","id":"30377120","link":"https://api.researchmap.jp/tyamazaki/awards/30377120","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377120]。"}]} ====== BulkResult(R000010784, h7bjho4BzHGxATo5UTtR) : End ====== ====== BulkResult(R000010784, jrbjho4BzHGxATo5Ujt6) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:59Z","end_datetime":"2024-03-28T21:25:59Z","estimated_end_datetime":"2024-03-28T21:26:00Z","total_items":60} --- success {"code":304,"status":"completion","start_datetime":"2024-03-28T21:25:59Z","end_datetime":"2024-03-28T21:25:59Z","estimated_end_datetime":"2024-03-28T21:26:00Z","total_items":60} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45575842","link":"https://api.researchmap.jp/tyamazaki/presentations/45575842","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45575842]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097339","link":"https://api.researchmap.jp/tyamazaki/presentations/37097339","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097339]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097340","link":"https://api.researchmap.jp/tyamazaki/presentations/37097340","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097340]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097341","link":"https://api.researchmap.jp/tyamazaki/presentations/37097341","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097341]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31858353","link":"https://api.researchmap.jp/tyamazaki/presentations/31858353","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31858353]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377094","link":"https://api.researchmap.jp/tyamazaki/presentations/30377094","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377094]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377095","link":"https://api.researchmap.jp/tyamazaki/presentations/30377095","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377095]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377096","link":"https://api.researchmap.jp/tyamazaki/presentations/30377096","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377096]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377097","link":"https://api.researchmap.jp/tyamazaki/presentations/30377097","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377097]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42454133","link":"https://api.researchmap.jp/tyamazaki/presentations/42454133","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42454133]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42125575","link":"https://api.researchmap.jp/tyamazaki/presentations/42125575","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42125575]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42125576","link":"https://api.researchmap.jp/tyamazaki/presentations/42125576","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42125576]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42125577","link":"https://api.researchmap.jp/tyamazaki/presentations/42125577","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42125577]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42910105","link":"https://api.researchmap.jp/tyamazaki/presentations/42910105","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42910105]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37152134","link":"https://api.researchmap.jp/tyamazaki/presentations/37152134","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37152134]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39716531","link":"https://api.researchmap.jp/tyamazaki/presentations/39716531","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39716531]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097344","link":"https://api.researchmap.jp/tyamazaki/presentations/37097344","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097344]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097345","link":"https://api.researchmap.jp/tyamazaki/presentations/37097345","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097345]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097346","link":"https://api.researchmap.jp/tyamazaki/presentations/37097346","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097346]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097347","link":"https://api.researchmap.jp/tyamazaki/presentations/37097347","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097347]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097348","link":"https://api.researchmap.jp/tyamazaki/presentations/37097348","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097348]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097349","link":"https://api.researchmap.jp/tyamazaki/presentations/37097349","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097349]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097350","link":"https://api.researchmap.jp/tyamazaki/presentations/37097350","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097350]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097351","link":"https://api.researchmap.jp/tyamazaki/presentations/37097351","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097351]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097352","link":"https://api.researchmap.jp/tyamazaki/presentations/37097352","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097352]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097353","link":"https://api.researchmap.jp/tyamazaki/presentations/37097353","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097353]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097354","link":"https://api.researchmap.jp/tyamazaki/presentations/37097354","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097354]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097355","link":"https://api.researchmap.jp/tyamazaki/presentations/37097355","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097355]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097356","link":"https://api.researchmap.jp/tyamazaki/presentations/37097356","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097356]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097357","link":"https://api.researchmap.jp/tyamazaki/presentations/37097357","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097357]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097358","link":"https://api.researchmap.jp/tyamazaki/presentations/37097358","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097358]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097359","link":"https://api.researchmap.jp/tyamazaki/presentations/37097359","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097359]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097360","link":"https://api.researchmap.jp/tyamazaki/presentations/37097360","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097360]。"}]} {"no":1,"line":34,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31858354","link":"https://api.researchmap.jp/tyamazaki/presentations/31858354","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31858354]。"}]} {"no":1,"line":35,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37097361","link":"https://api.researchmap.jp/tyamazaki/presentations/37097361","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37097361]。"}]} {"no":1,"line":36,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31858355","link":"https://api.researchmap.jp/tyamazaki/presentations/31858355","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31858355]。"}]} {"no":1,"line":37,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31858356","link":"https://api.researchmap.jp/tyamazaki/presentations/31858356","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31858356]。"}]} {"no":1,"line":38,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377098","link":"https://api.researchmap.jp/tyamazaki/presentations/30377098","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377098]。"}]} {"no":1,"line":39,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377099","link":"https://api.researchmap.jp/tyamazaki/presentations/30377099","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377099]。"}]} {"no":1,"line":40,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377100","link":"https://api.researchmap.jp/tyamazaki/presentations/30377100","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377100]。"}]} {"no":1,"line":41,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377101","link":"https://api.researchmap.jp/tyamazaki/presentations/30377101","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377101]。"}]} {"no":1,"line":42,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377102","link":"https://api.researchmap.jp/tyamazaki/presentations/30377102","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377102]。"}]} {"no":1,"line":43,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377103","link":"https://api.researchmap.jp/tyamazaki/presentations/30377103","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377103]。"}]} {"no":1,"line":44,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377104","link":"https://api.researchmap.jp/tyamazaki/presentations/30377104","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377104]。"}]} {"no":1,"line":45,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377105","link":"https://api.researchmap.jp/tyamazaki/presentations/30377105","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377105]。"}]} {"no":1,"line":46,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377106","link":"https://api.researchmap.jp/tyamazaki/presentations/30377106","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377106]。"}]} {"no":1,"line":47,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377107","link":"https://api.researchmap.jp/tyamazaki/presentations/30377107","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377107]。"}]} {"no":1,"line":48,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377108","link":"https://api.researchmap.jp/tyamazaki/presentations/30377108","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377108]。"}]} {"no":1,"line":49,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377109","link":"https://api.researchmap.jp/tyamazaki/presentations/30377109","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377109]。"}]} {"no":1,"line":50,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377110","link":"https://api.researchmap.jp/tyamazaki/presentations/30377110","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377110]。"}]} {"no":1,"line":51,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377111","link":"https://api.researchmap.jp/tyamazaki/presentations/30377111","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377111]。"}]} {"no":1,"line":52,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377112","link":"https://api.researchmap.jp/tyamazaki/presentations/30377112","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377112]。"}]} {"no":1,"line":53,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377113","link":"https://api.researchmap.jp/tyamazaki/presentations/30377113","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377113]。"}]} {"no":1,"line":54,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377114","link":"https://api.researchmap.jp/tyamazaki/presentations/30377114","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377114]。"}]} {"no":1,"line":55,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377115","link":"https://api.researchmap.jp/tyamazaki/presentations/30377115","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377115]。"}]} {"no":1,"line":56,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377116","link":"https://api.researchmap.jp/tyamazaki/presentations/30377116","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377116]。"}]} {"no":1,"line":57,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377117","link":"https://api.researchmap.jp/tyamazaki/presentations/30377117","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377117]。"}]} {"no":1,"line":58,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377118","link":"https://api.researchmap.jp/tyamazaki/presentations/30377118","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377118]。"}]} {"no":1,"line":59,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30377119","link":"https://api.researchmap.jp/tyamazaki/presentations/30377119","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30377119]。"}]} {"no":1,"line":60,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312375","link":"https://api.researchmap.jp/tyamazaki/presentations/33312375","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312375]。"}]} ====== BulkResult(R000010784, jrbjho4BzHGxATo5Ujt6) : End ======